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My son was ill since birth, and at the age of six months he was diagnosed with HIV. The boy’s mother and 
he tested positive and I tested negative. It was the most frightening moment of my life. I was told that my 
son would not live beyond three years of age, and I decided that I would make his life as rich and joyful as 
possible. Despite the medical advice I remained positive, provided my son with everything he needed to 
thrive, and constantly hoped that there would be a miraculous cure for him. He lived each day fully, was 
completely adherent to the medical regimen prescribed, and disclosed to everyone in my family circle about 
what my son was dealing with. Because of my son’s HIV status I immersed himself in caring for him and 
started reading everything I could find about the disease. I retired from my business went back to college 
so that I could study psychology. The invitation to serve on the Community Advisory Board of Children’s 
Hospital (University of California State) presented an opportunity of meeting several members of the South 
African Research teams doing research into youth and adolescent medication adherence. I travelled to South 
Africa where I started running camps for children attending the Infectious Diseases Unit at Tygerberg 
Hospital.  Compared to HIV-infected children in California, families in Cape Town had extremely limited 
resources at their disposal. My son was his own advocate and could confidently disclose his status to others 
from the age of four years. After realising that parents were not disclosing their children’s HIV status to 
them, I decided to focus my research on disclosure patterns with the purpose of helping to establish a 
disclosure process with clinical staff so that parents could be supported in this challenging task.  
 
When I enrolled in the master’s programme at the University of Cape Town (UCT) my son developed B-
cell lymphoma, and he was seriously ill. I had deferred my studies to return to the U.S. and care for him. It 
was the most difficult years of my life, and I could not complete this research as planned. Sadly, he passed 
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3Tc  Lamivudine 
AIDS  Acquired immune deficiency syndrome 
ALHIV Adolescents living with HIV  
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CLH  Children living with HIV 
d4T  Stavudine 
HAART Highly active antiretroviral therapy 
HIV  Human immunodeficiency virus 
MTCT  Mother-to-child-transmission 
BMSM Black men who have sex with men  
NVP  Nevirapine 
PLHAs People living with HIV & AIDS  
PMTCT Prevention of mother-to-child-transmission 
RXH  Red Cross War Memorial Children’s Hospital 
SDG  Sustainable development goal  
UCT  University of Cape Town  
UN  United Nations 
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DEFINITION OF TERMS 
 
Adolescent:  Refers to any person between the ages of 10 and 19 years of age (World Health 
Organisation [WHO], 2018a). 
Adolescence:  Adolescence is a transitional phase of growth and development that extends 
between childhood and adulthood. Although ages 10 to 19 years is sometimes 
regarded as the adolescent period, biological age is appropriate for assessing 
biological age, and does not take into account the nuanced psychosocial transitions 
that occur in adolescence (WHO, 2018a). 
Caregiver: A caregiver is anyone who cares for child in their own environment on a regular 
basis. The caregiver is related to the child receiving care, and is not a professional 
caregiver (Schoenmakers, Buntinx, & Delepeleire, 2010).   
Child: Any person under the age of 18 years of age, unless married or emancipated by a 
court order (Constitution of the Republic of South Africa, No. 108 of 1996; 
Children’s Act No. 30 of 2005). 
Child disclosure: Child disclosure refers to an HIV-infected child being told their HIV status by a 
parent or caregiver, or the child’s disclosure of their HIV status to others (Lesch et 
al., 2007). 
Parental disclosure: In this study disclosure refers to the primary caregiver’s perception of having told 
an HIV-infected child about the HIV & AIDS diagnosis (Vreeman et al., 2013). 
Social support: Social support is defined as:” supportive functions performed for the individual by 
significant others, such as family members, friends, and co-workers (Thoits, cited 
in Bekelele et al., 2013, p. 337). 
Stigma: Stigma is described as: “a negative attribute that is mapped onto people who, by 
virtue of being different, are understood to be negatively valued in society” 
(Stuber, Meyer, & Link, 2008, p. 5) 
Youth: The term young people and youth applies to people between the ages of 10 and 24 
years of age (WHO, 2018a). In South Africa youth refers to persons between the 













A cross-sectional, descriptive study combining with open-ended (qualitative) interview questions with 
quantitative component was conducted to explore disclosure experiences of mothers and caregivers of HIV-
infected children. The study was conducted with 102 parents and caregivers at a tertiary hospital in Cape 
Town delivering care to 303 HIV-infected paediatric patients. The study sample included 102 participants, 
ranging in age from 16 years to 71 years. The sample included 73 mothers (72%), six fathers (6%), 11 
foster-mothers (11%), and 12 caregivers or grandmothers (12%). The median age of participants’ children 
was 4 (IQR 2-8) years and ranged from five months to 16 years. Only 48 (47%) were old enough for 
disclosure to be possible. Disclosure or disclosure delay was associated with several factors, including the 
child’s age or ability to understand, anxiety and guilt about being blamed for infecting the child, fear of 
exposing the child to stigma, discrimination and social exclusion related to the child disclosing to others, 
and the hope that the child would be adherent if they understood their illness and the way in which the 
medication could improve their health outcomes. Only 16 (33%) of 48 participants actually disclosed the 
child’s HIV status. The results indicate that HIV-disclosure remains a challenging, emotionally-charged 
experience for mothers and caregivers. The findings of this research, and similar studies, point to the value 
of integrating disclosure support and planning into routine care for children and adolescents, as well as their 


















CHAPTER ONE: BACKROUND AND INTRODUCTION 
 
This dissertation is located at the juncture of human immunodeficiency virus (HIV) infection and child 
well-being.  This chapter presents the connectedness of HIV and child well-being as a backdrop and 
rationale for the current study. The purpose of this chapter is not to provide a comprehensive discussion of 
each of the concepts, but instead aims to provide a contextual background to the study. 
 
1.1.Background and Introduction 
 
The number of AIDS-related deaths in children aged 0-14 years is steadily declining, from 210,000 in 2010 
to 120,000 in 2016 (Joint United Nations Programme on HIV & AIDS [UNAIDS], 2017). The rapid scale-
up of antiretroviral medication (ART) made available to pregnant women through the prevention-of-
mother-to-child-transmission (PMTCT) programme increased from 47% in 2010, to 76% in 2016 
(UNAIDS, 2017). In children the number of new infections dropped by 47%; this trend could be attributed 
to enhanced PMTCT coverage and improved access to highly active antiretroviral therapy (HAART) for 
children. Improved survival and health outcomes in HIV infected children draws attention to the 
psychosocial challenges related to growing up with a chronic, potentially life-threatening, stigmatised 
illness (Mutumba et al., 2015; Tadesse, Foster, & Berhan, 2015). As HIV infected children transition into 
adolescence, they must negotiate issues of disclosure, stigma, and practicing safer sex (Madiba & Mokgatle, 
2016). Improved access to antiretroviral medication and the associated positive health outcomes and 
survival makes HIV disclosure to children and adolescents an important aspect of HIV management (Vaz, 
Eng, Maman, Tshikandu, & Behets, 2010; Kenu et al., 2014). 
 
In 2010 it was estimated that 30% of all pregnant women attending antenatal clinics in South Africa (SA) 
were HIV-infected (Barron et al., 2013). In October 2015 HIV prevalence among antenatal attendees was 
30.8% (National Department of Health [NDoH], 2017). The alarmingly high maternal seroprevalence, with 




infection results in paediatric HIV infection becoming a sizeable public health problem in SA. An estimated 
184,680 children are living with HIV, with 303 receiving care at Red Cross War Memorial Children’s 
Hospital (RXH) in Cape Town (Dr J. Nuttal, personal communication, 2016). In a study conducted in two 
centres in SA, the availability of simpler, cost-effective methods for diagnosing HIV, as well as the 
availability of affordable and appropriate paediatric antiretroviral (ARV) regimens was found to reduce 
HIV-related child mortality by 76%, with a reduction disease progression by 75% (Violari et.al., 2008). 
Ironically, the second significant consequence occurs when HIV-infected children access antiretroviral 
therapy (ART) and have a reduced risk of dying during childhood, precipitating the need for explaining 
their diagnosis (Kenu et al., 2014; Midtbø, Shirima, Skovdal, & Daniel, 2012; Mutumba et al., 2015).   
 
Disclosing an HIV status to a child remains one of the most challenging aspects of the disease (Kenu et al., 
2014; Pantelic, Shenderovich, Cluver, & Boyes, 2015). For parents and caregivers, knowing when and how 
to start the disclosure process to children can be daunting and anxiety-provoking (Evangeli & Kagee, 2016). 
Although HIV disclosure has received significant attention in the past two decades, the actual disclosure 
process remains challenging and uncertain (Das, Detels, Javanbakht, & Panda, 2016). This is of particular 
significance in low-income countries (LICs) in sub-Saharan Africa (SSA) where HIV remains a heavily 
stigmatised disease (Pantelic et al., 2015). Explaining an HIV diagnosis to children and adolescents can be 
particularly confusing to those who are asymptomatic (Kenu et al., 2014). HIV non-disclosure could in fact 
impede access to treatment for infected children, which could be detrimental to their health and well-being 
(Gyamfi, Okyere, Enoch, & Appiah-Brempong, 2017). Reported disclosure concerns relate to fears about 
children’s cognitive and emotional development, capacity to understand, their ability to cope with the 
illness, being stigmatised, concerns about emotional support, and concerns about the implications for social 
relationships (Gyamfi et al., 2017; Oberdorfer et al., 2006; World Health Organisation [WHO], 2011). 
WHO recommends that children of school-going age be told their HIV status, and that younger children be 




Mother-to-child transmission (MYCT) of HIV 
The United Nations AIDS (UNAIDS) Report 2014 indicated that at least 19 million of the 35 million people 
infected with HIV are unaware of their HIV status (UNAIDS, 2014). Despite the increasing availability to 
HIV screening through PMTCT programme, 54% of pregnant women in low- and middle-income countries 
(LMICs) do not have an HIV test during the antenatal period. Vertical HIV transmission rates remain high, 
ranging from 15% to 45% (WHO, 2018b). In 2010 it was estimated that 30.2% of all women attending 
antenatal clinics in South Africa (SA) were HIV-infected, and at least 70.4% of all maternal deaths in 2011 
were HIV-related (Barron et al., 2013). Testing infants for HIV in SA before the age of two months 
increased from 36.6% in 2008, to 70.4% in 2011 (Barron et al., 2013). During that period the number of 
children who tested positive declined from 9.6% in 2008, to 2.8% in 2011 (Sherman et al., 2012). In 2015 
MTCT increased from 4.9% at six weeks of age, to 8.9% at the end of the breastfeeding period (UNAIDS, 
2016). Of the number of children infected with HIV, approximately one third die before their first birthday, 
and half die by their second birthday. Once the diagnosis is confirmed and children are started on 
antiretroviral treatment, HIV-related mortality can be reduced by as much as 75% (UNAIDS Gap Report, 
2014). Fast-tracking progress toward the elimination of MTCT requires improvements in access to lifelong 
ART, as well as appropriate attention to the complex psychosocial factors that negatively affect care-
seeking, disclosure, and retention in care (Prudden et al., 2017). 
 
South Africa introduced WHO’s “Option B+” in April 2013, to replace “Option A”. The new treatment 
regimen provided all HIV-positive women a three-drug ART for the duration of the pregnancy and 
breastfeeding period, irrespective of the mother’s baseline CD4 count (Maskew et al., 2018). Despite these 
modifications, a prospective cohort study conducted at a primary health care clinic in Johannesburg, South 
Africa found that although ART-initiation in pregnancy was starting at an earlier gestational age, ART 




infants attending baby follow-up services tested HIV-positive at four to eight weeks of age (Burton, Giddy, 
& Stinson, 2015).  
Importance and benefits of HIV Disclosure 
An ill child is a concern to family members. Once the child’s health has stabilised, caregivers are tasked 
with the responsibility of HIV disclosure. For many children the discovery of their positive HIV status is 
secondary to an episode of illness (Tadesse, Foster, & Berhan, 2015); hence the diagnosis is often a 
shocking and unpleasant surprise. Informing children living with HIV (CLH) of their status is important 
from the clinical diagnostic and treatment significance, as well as the overall psychological well-being 
perspective (Das et al., 2016; Prudden at al., 2017). Challenges that parents and caregivers have to consider 
include when to disclose, how to disclose, who should disclose, how much to disclose, and what is in the 
child’s bests interest (Kenu et al., 2014). HIV disclosure carries benefits for parents as well as children 
living with HIV. Parents who disclose their HIV status to children reportedly experience stress and anxiety 
to a lesser degree than those who do not. Disclosure allows the child to ask questions, clarify 
misconceptions, adjust to the situation, grieve, and access social support (Ostrom Delaney, Serovich, & 
Lim, 2008; Kenu et al., 2014). In a cross-sectional study conducted with 71 mother-child dyads in Ghana, 
researchers found that HIV disclosure helped children to understand their illness and treatment, which 
improved participation in disease management (Kallem, Renner, Ghebremichael, & Paintsil, 2011). 
Children who were told their HIV status tend to have better self-esteem than those who do not know their 
status, and tend to experience less psychological distress (Domek, 2010). Moreover, children’s awareness 
of their HIV status is associated with improved medication adherence (Kallem et al., 2011; Tadesse et al., 
2015; Vreeman et al., 2010; Vreeman et al., 2013).  
 
Barriers to HIV status disclosure  
Disclosure is a significant component of long-term HIV management, and an essential step for children as 




Kenya by Vreeman et al. (2010) only two caregivers in a sample of 120 study participants explained to the 
child why they were taking ARVs. The main reason for delaying disclosure was caregivers’ fear of adverse 
psychological consequences (Oberdorfer et al., 2006). In a cross-sectional study conducted with 177 
children in Southern Ethiopia, caregiver reasons for non-disclosure of the child’s HIV status included fear 
of hurting the child’s feelings, fear of self-harm, concerns that the child might not be able to accept the 
information, and fear that the child might refuse to continue taking the medication (Tadesse et al., 2015). 
In a cross-sectional study conducted in Ghana with 118 caregivers of HIV-infected children, the main 
reasons for non-disclosure were fears that the child might be too young to understand, the desire to protect 
the family from shame, the effect of disclosure on the mother-child relationship, the effect of disclosure on 
the child’s emotional and psychological well-being, and the fear that the child might perceive the mother 
as having led an irresponsible life (Gyamfi et al., 2017). Maternal non-disclosure could cause children to 
read into the signs related to bouts of illness, hospital visits, and hospitalisation, which could result in 
anxiety and fear (Ostrom Delaney et al., 2008). Non-disclosure can be detrimental to child and adolescent 
well-being as it could be a barrier to care when cooperation and treatment adherence behaviour are being 
developed (Lesch et al., 2007; Tadesse et al., 2015). 
 
1.2. Motivation and Justification for the Study 
Paediatric HIV & AIDS affects children in significant ways, including physiological, psychological, and 
social ways. Emerging evidence suggests that children are profoundly affected by their HIV status and face 
an increased risk of developing mental health problems associated with stress emanating from parental loss, 
lack of social support, social exclusion, feelings of shame, and poor body image (Dow et al., 2016; Lam et 
al., 2007). They often feel betrayed and many experience confusion, depression, anxiety, fear, anger, guilt 
and loneliness (Brown & Lourie, 2000; Dow et al., 2016; Ruiz, 2000). Appropriate attention to the 
psychosocial needs of HIV-infected children tends to lag behind responses to biomedical aspects of the 




that can adversely affect children’s coping and general sense of emotional wellbeing (Earnshaw & 
Chaudoir, 2009). Children who know of their parents’ HIV serostatus often have to cope with stigma as 
well as their fears about the potential loss of a family member (Dow et al., 2016; Wiener et al., 2000).  
 
The availability of improved paediatric ART regimens has transformed HIV & AIDS in children from a 
rapidly terminal disease to a longer-term chronic condition (Gillard & Roark, 2013; Kenu et al., 2014). HIV 
care is a process involving caregivers and the paediatric patient through all their developmental stages and 
disclosure is one of the crucial steps in the process. Non-disclosure to children can result in feelings of 
loneliness, emotional and psychological distress and the fear that there is something so seriously wrong that 
it has to be kept secret (Domek, 2005). Caregivers often defer disclosure or fail to disclose at all. Surrounded 
by the fear of stigma, abandonment and social isolation, there are often significant social, cultural traditions 
and circumstances that have to be taken into account when preparing caregivers to disclose to an HIV-
infected child (Domek, 2005; Ostrom Delaney et al., 2008).  
 
Children and caregivers change and develop over time, therefore different ages require different responses 
and different kinds of information about their health status. Depending on the child’s age, non-disclosure 
is likely to create different degrees of adjustment difficulty (Kenu et al., 2014). For example, for the child 
under four years of age, disclosure may not be as significant for the child aged 5-6 years preparing to enter 
pre-school or grade one, a period when the child’s social circle expands greatly. At age 10-12 years, the 
pre-pubertal and pubertal stage, the child is looking forward to the major shift in their sense of self in the 
social circle, where body image and social acceptance amongst peers becomes paramount (Gyamfi et al., 
2017; Kenu et al., 2014; Lester et al., 2002; Papalia et al., 2001). Disclosure at this point, depending on 
how it is handled, can have a devastating impact on the child’s development. Managing a chronic condition 
requires ongoing disclosure and re-disclosure because each time the child engages with a change in their 




(Gyamfi et al., 2017; Lesch et al., 2007; WHO, 2011). This suggests that with advancing age of the child, 
caregivers and health providers’ way of relating to the children needs to be adjusted (WHO, 2011). WHO 
recommends that disclosure should be incorporated into the long-term HIV management plan, and that 
younger children should be informed about their health status incrementally, to accommodate their 
emotional and cognitive level of maturity (Gyamfi et al., 2017; WHO, 2011). 
 
A critical analysis of the way in which the social context interacts with personal and interpersonal factors 
to influence disclosure practices to HIV-infected children, at different developmental stages, is essential 
for the delivery of comprehensive paediatric HIV care. Elements of this study could be used to guide the 
formulation of culturally sensitive strategies for facilitating disclosure at significant developmental stages 
in HIV-infected children. 
 
1.3. Research Questions 
The study was guided by three questions: 
• What factors inform parents/caregivers’ decision to disclose their health status to HIV-infected 
children? 
• What are the consequences of disclosure for children and their caregivers? 
• How do HIV-infected children respond to disclosure? 
 
1.4. Research Aim 
The aim of the study was to explore patterns and challenges associated with disclosure to HIV-infected 
children as a basis for developing culturally appropriate strategies for facilitating disclosure.  
 
1.5. Research Objectives 
1. To determine general disclosure trends in children receiving ARTs at Red Cross War Memorial 




2. To explore caregiver’s perceptions and experiences with disclosure to HIV-infected children 
receiving care at RXH in Cape Town, South Africa.  
3. To explore HIV-infected caregiver perceptions about their children’s understanding about their 
health status and experiences with disclosure. 
4. To make recommendations that could assist caregivers to disclose to children who are HIV positive.  
 
1.6. Summary 
The first chapter presented a brief background and introduction to the study. Chapter two is a presentation 
of the literature review on the topic, and chapter three provides details about the research methodology 
applied in the study. In chapters four and five the findings of the study are presented and discussed. 
Chapter six summarises the findings and limitations of the study, and presents recommendations based on 






























CHAPTER TWO: REVIEW OF THE LITERATURE 
 
2.1. Introduction 
This chapter presents a review of the literature pertaining to HIV disclosure to the infected child. The 
chapter starts with a description of the background to HIV & AIDS, followed by the diverse dimensions of 
the disclosure process. 
 
2.2. Review Methodology 
The review draws on literature up to and including 2017 identified using keyword searches of electronic 
databases. The main keywords used in the search were “HIV & AIDS” and “paediatric” with “disclosure”. 
Other search terms applied were “HIV disclosure to children” and “effects of HIV disclosure in children”. 
Additional searches were conducted using the terms “HIV and social support” and “HIV and stigma”. 
Databases accessed included Ebscohost, ScienceDirect, PubMed, CINAHL, and PsychInfo. 
 
2.3. Background to HIV 
HIV was first identified in 1984 by Luc Montagnier and colleagues at the Institut Pasteur of France. 
Transmission of the virus to the newborn can occur in utero, intrapartum, or postnatally through breast-
feeding (Magder et al, 2005) resulting in 3.4 million children under the age of 15 years living with HIV 
(UNAIDS 2010 Global Report on the Global AIDS Epidemic). Intrapartum transmission of HIV from 
mother to child occurs primarily through direct contact of the fetus with the virus in the genital tract (Thorne 
& Newell, 2004). While the administration of single-dose Nevirapine has proved to significantly reduce 
vertical transmission of HIV to the newborn, postnatal transmission of the virus through breastfeeding 
remains a concern (Magoni et al, 2005; Leroy et al, 2003; Jackson et al, 2003). We know from several 
studies that the estimated risk of HIV transmission through breastfeeding doubles the overall risk of mother-
to-child -transmission (MTCT), contributing a significant 16% to MTCT rates (Thorne and Newell, 2004; 




mothers alive has contributed substantively to identifying and implementing interventions for preventing 
MTCT (UNAIDS, 2016). Since the implementation of the UNAIDS Global Plan in 2011, worldwide the 
number of new infections in children decreased by 60% (UNAIDS, 2015). 
 
2.4. HIV Prevalence 
Globally there are approximately 36.7 million people living with HIV, with 2.1 million being children <15 
years of age (UNAIDS Fact Sheet, 2017).  In 2016 young women aged 15 to 26 years in eastern and 
southern Africa accounted for 26% of new infections. Of the estimated 5000 new HIV infections per day, 
64% are from sub-Saharan Africa (SSA), and 400 new infections occur in children <15 years of age 
(UNAIDS, 2017). Women carry more than half (58%) of the HIV-infection burden in SSA. Of the 4500 
new HIV infections, 43% are women aged 15 years of age and older (UNAIDS, 2017). In 2013 the number 
of cases of HIV infection was 2.1 million, a 38% decline from the 3.4 million new cases of HIV reported 
in 2001. In 2002 the number of new infections in children was 580 000. By contrast the number of new 
infections in children in 2013 was 240 000, a reduction of 58% (UNAIDS Gap Report, 2014).   
 
Despite the increasing availability of HIV screening through the prevention–of-mother-to-child-
transmission (PMTCT) programme, 54% of pregnant women in low- and middle-income countries 
(LMICs) do not have an HIV test during the antenatal period. Notwithstanding the low uptake of the 
PMTCT intervention during the antenatal period, vertical transmission of HIV in LMICs declined from 
between 20-40% to 2.8% in well-performing countries. In wealthy countries the vertical transmission rate 
is below two percent (Grimwood et al., 2012). Although the dramatic decline in new infections in children 
is attributed to the provision of antiretroviral medication for pregnant women, in 2015 MTCT increased 
from 4.9% at six weeks to 8.9% at the end of breastfeeding (UNAIDS, 2016). The rate of mother-to-child-
transmission (MTCT) in mothers who do not receive ART ranges from 15% to 45% (WHO, 2018b). 




among children by 2015 and keeping their mothers alive was rolled out the mother-to-child-transmission 
rate was 25.8% in 2009 (UNAIDS, 2015). Since the Global Plan was launched in July 2011, the rate 
decreased to 15.7% (UNAIDS Gap Report, 2014). In 2016, approximately 76% of pregnant women had 
access to ART to prevent vertical transmission to their babies (UNAIDS Fact Sheet, 2017). Furthermore, 
in approximately 25% of pregnant women who tested HIV-positive, lifelong ART was not initiated 
(Prudden et al., 2017). Despite the 50% decline in the number of new cases of HIV infection in children in 
SA, in high-prevalence areas it is estimated that at least 40% of pregnant women are infected, resulting in 
vertical HIV transmission to children (Rochat, Mkwanazi & Bland, 2013; UNAIDS Gap Report, 2014). 
Since 2009, new infections in children in SA were reduced by 84% (UNAIDS, 2016). Improving access to 
lifelong ART relies on expanding the supply of PMTCT services, as well as ARV treatment programmes 
(Prudden et al., 2017). Moreover, structural barriers to HIV prevention, screening, treatment and support 
services, like non-disclosure and stigma, demand appropriate attention if MTCT prevention goals, and 
Sustainable Development Goal (SDG) 3 (United Nations [UN], 2015) that addresses the health outcomes 
of women, newborns, children, and adolescents (Prudden et al., 2017).   
 
2.5. HIV and Stigma 
Stigma is recognised as a significant barrier to accessing HIV prevention, testing, and treatment services 
(Mahajan et al., 2008; Prudden et al., 2017) and is a considerable barrier to HIV disclosure (Abebe & 
Teferra, 2012; Prudden et al., 2017). According to Goffman, stigma “occurs when a person or group 
possesses a particular attribute that is viewed by others in society as an undesirable difference” (cited in 
Harper, Lemos, & Hosek, 2014, p. 543). Goffman established that society stigmatises on the basis of what 
is perceived as difference or deviance (Goffman, cited in Mahajan et al., 2008). Viewed as a psychological 
stressor, stigma manifests either as anticipation of negative treatment by others, or as a self-directed 
internalisation of negative views held by others (Stuber, Meyer, & Link, 2008).   In their systematic review 




(PLHAs) are labelled and stereotyped by society on the basis of false beliefs, attitudes, and fears. Stigma is 
not constrained to individual perceptions and is interwoven into the social interactions and processes of 
families, groups, communities, and society (Mahajan et al., 2008). Wilson et al. (2016) in their systematic 
review of qualitative studies examining stigma in the context of Black men who have sex with men 
(BMSM) reported institutional and community-level stigma related to sexuality, femininity, and HIV & 
AIDS acquisition vulnerability.  Societal stigma linked to low socioeconomic status, race, ethnicity, and 
gender discrimination tends to reinforce secrecy and reluctance to disclose (Eilson et al., 2016). 
Discrimination is consequent to stigmatisation, and results in unfair and unjust treatment (Smith, Rossetto, 
& Peterson, 2008). Parker and Aggleton (cited in Mahajan et al., 2008) proposed that stigma functions at 
the intersection of relations of power and control. The outcome of stigma is social distancing, limiting social 
opportunities, and lack of support (Mahanjan et al., 2008; Smith et al., 2008). Marginalised groups such as 
non-white heterosexual men and women, gay men, injection drug users, and sex workers emerged as 
particularly vulnerable to stigma in the context of HIV & AIDS (Wilson et al., 2016). Social exclusion 
affects marginalised groups economically, politically and socially. Stigmatisation of marginalised people 
disallows them the privilege of economic and social opportunities available to others. This also applies to 
access to health services (Cáceres et al., 2008). Consequently, PLHAs may be hesitant to disclose their HIV 
status to others, to protect themselves, their family, and friends against potential rejection and 
discrimination (Smith et al., 2008). To avoid rejection, PLHAs tend to resort to secrecy, deception, and 
social withdrawal to avoid rejection (Smith et al., 2008). HIV-related stigma and discrimination are social 
processes linked to inequality and exclusion, with potential adverse psychological, social, and biological 
consequences (Stuber et al., 2008). Stigma and discrimination at the family and community level, as well 
as within health services, are recognised as significant social barriers to PMTCT access and retention 






2.6. HIV and Social Support 
The relationship between perceived or received social support and improved quality of life for adults 
infected with HIV is well-recognised (Bekele et al., 2013; Liu et al., 2006; Uphold et al., 2005). Social 
support is defined as:” supportive functions performed for the individual by significant others, such as 
family members, friends, and co-workers (Thoits, cited in Bekelele et al., 2013, p. 337). Social support was 
shown to have a positive impact on medication adherence, improvements in CD4 count, and a reduction in 
HIV symptoms (Bekele et al., 2013). Support can be categorised as emotional, informational, and 
instrumental. Emotional support is reflected in caring and empathy; informational support includes 
counseling, advice, and encouragement; and practical support includes assisting with housework, childcare, 
and the provision of food, accommodation, or money (Kimani‐Murage, Manderson, Norris, & Kahn, 2010). 
Two fundamental ways in which support benefits people living with HIV is by having a positive effect on 
well-being (main effects model) or by reducing the detrimental effects of stressors (stress-buffering model). 
In a health survey conducted with 602 adults living with HIV in Ontario, Canada to examine how perceived 
or received social support contributes to physical and mental well-being, the results showed that social 
support had an overall beneficial effect on health-related quality of life (HRQOL) (Bekele et al., 2013). 
Similarly, in a study conducted in Ethiopia to explore the association between depressive symptoms and 
perceived social support on weight gain and CD4 cell counts, Alemu et al. (2012) found that perceived 
social support had a positive effect on weight gain and CD4 cell progression. Among the range of support 
functions, emotional support is thought to have the most significant bearing on overall well-being (Zhao et 
al., 2011).  
The well-being of children and the parents or caregivers tends to be intricately intertwined, and medication 
adherence in children is affected by the level of caregiver stress and quality of life (QOL), caregiver 
functioning, and the quality of caregiver-child communication (Merzel, VanDevanter, & Irvine; 2008). 
Social support is recognised as a salient resource and mediating factor for coping with the challenges of 




to be a significant deterrent to accessing external support, as well as disclosure of the child’s HIV status. 
Parents and caregivers who struggle to maintain their child’s HIV medication adherence might shy away 
from seeking support from family, friends, neighbours and community members as a result of non-
disclosure and fear of stigma (Midtbø et al., 2012). 
 
2.7. HIV Disclosure 
In this study disclosure was explored from the perspective of the parents or caregivers; hence disclosure is 
understood as the primary caregiver’s perception of having told an HIV-infected child about the HIV & 
AIDS diagnosis (Vreeman et al., 2013). Child disclosure refers to an HIV-infected child being told their 
HIV status by a parent or caregiver, or the child’s disclosure of their HIV status to others (Lesch et al., 
2007). Disclosure can take the form of a single event, or a gradual process (Madiba & Mokwena, 2012; 
Mahloko & Madiba, 2012). Several researchers have studied disclosure patterns and found that disclosure 
trends vary broadly, ranging from vague misrepresentations like telling the child that they take medicine to 
look after themselves or hiding the child’s HIV status behind illnesses like allergy, tuberculosis, liver 
disease or cancer to telling the child that they have the same disease as the caregiver without using the terms 
HIV or AIDS (Kenu et al., 2014; Oberdorfer et al., 2006; Ledlie, 1999; Lee & Rotheram-Borus, 2002; 
Lesch et al., 2007). Some caregivers have reported telling the child that they have a germ in their blood and 
others have disclosed completely using the terms HIV & AIDS (Oberdorfer et al., 2006; Ledlie, 1999, Lee 
& Rotheram-Borus, 2002). Based on these insights, complete parental disclosure is defined as a situation 
in which the primary caregiver and child agree that the child was told about their disease, using the terms 
HIV or AIDS as well as the way in which ART works to improve health outcomes (Bimaako-Kajura et al., 
2006).   
 
Eustace and Ilagen (2010) described the HIV disclosure process as containing antecedents and 




include individual, family, community, and social factors (Eustace & Ilagen, 2010). Post diagnosis factors 
include disease acceptance, the desire to protect others, and the need for social support. The consequences 
of HIV disclosure could be experienced as either negative or positive, in relation to the reactions of family, 
loved ones, friends, community, and co-workers (Eustace & Ilagen, 2010). Negative consequences could 
include anxiety related to fear of rejection, stigma, discrimination, loss of love and support, and social 
isolation. Positive consequences include acceptance, social support, improved relationships, improved 
adherence, and retention in care (Eustace & Ilagen, 2010). 
 
Disclosure can be anxiety-provoking for parents who often feel a deep sense of guilt about passing the 
infection to their child. In a study conducted to explore HIV care-seeking behaviours for HIV-infected 
children in rural SA, caregivers feared that confidentiality would be broken by health providers (Kimani-
Murage, Manderson, Norris, & Kahn, 2013). Disclosure was reportedly associated with high perceived 
social costs, with detrimental effects on the child’s development (Kimani-Murage et al., 2013). 
Additionally, AIDS is highly stigmatised in most societies as it is perceived to be a consequence of socially 
unacceptable behaviours like sexual promiscuity, drug use and homosexuality (Wiener et al., 2000). 
Oberdorfer et al (2006) in their disclosure study conducted in Thailand found the fear of negative emotional 
consequences for children to be the main reason for delayed disclosure.  Reported negative emotional 
consequences include distress, depression, anxiety, discrimination and isolation (Oberdorfer et al., 2006). 
 
Factors supporting disclosure 
Emerging evidence demonstrates a positive correlation between complete parental disclosure, ART 
adherence and health outcomes (Abebe & Teferra, 2012; Bikaako-Kanjura et al., 2006; Gyamfi et al., 2017; 
Kenu et al., 2014; Lawan, Envaladu, & Abubakar, 2016). Caregivers report that children who know their 
HIV serostatus and understand how the medication works to protect their health are “self-motivated to 




children tend to trust that the drugs will prevent them from getting ill, are generally less dependent on their 
caregivers, and develop their own adherence strategies. In a multi-centre cohort study conducted in five 
paediatric clinics to explore retention in care among HIV-infected children aged 10 years or more in Cote 
d’Ivoire, Mali and Senegal, the researchers found that retention in care was higher in those adolescents who 
knew their HIV status compared to those to whom their HIV status had not been disclosed (Arrivé et al., 
2012). Similarly, in a study conducted to evaluate whether selective disclosure or non-disclosure was 
associated with retention in care, non-disclosure was significantly associated with poor retention in care 
(Alopre et al., 2015). 
 
Children who experienced complete parental disclosure generally enjoy supportive, trusting relationships 
and adherence is understood to be a shared responsibility (Bikaako-Kanjura et al., 2006). Lawan et al. 
(2016) used a case study approach with 400 HIV-infected adolescent children attending an ART clinic in 
northern Nigeria to examine the disclosure  and awareness status of adolescents. The results showed that 
two-thirds of adolescent participants (251) knew their HIV status, compared to 149 who did not know their 
status. HIV awareness was positively correlated with age, sex, level of education, and the level of education 
of mothers (Lawan et al., 2016). HIV awareness was found to play a key role in HIV prevention and risk 
behaviour (Lawan et al., 2016).  Positive outcomes associated with HIV disclosure to children and 
adolescents include better understanding of their health status, cooperation with medical regimens, 
improved adherence, improved utilisation of clinical support services, fewer behavioural difficulties, 
establishing trust, and improved communication of fears and anxiety (Lawan et al., 2016). 
 
Factors inhibiting disclosure 
Disclosure to an HIV-infected child can be intensely anxiety and fear-provoking and caregivers try to avoid 
disclosure as long as possible (Abebe & Teferra, 2012). Non-disclosure affects child well-being by 




et al., 2017). The decision to disclose HIV status to a child is informed by the interaction of several 
compelling factors. In addition to personal processes and the subjective experiences of social influences, 
there are objective environmental, social, economic and political considerations. Beliefs about the difficulty 
with accepting their HIV serostatus and diminished ability to cope with their own illness may prevent 
parents from disclosing to their children.  Parents may also feel guilty about infecting their child and fear 
anger or rejection from their children (The American Academy Committee on Paediatric AIDS, 1999; 
Vreeman et al., 2013). Several studies report that parents often decide to protect their children against what 
they perceive to be potentially harmful knowledge and negative experiences, believing that the child is 
better off not knowing (Claflin & Barbarin, 1991; Funck-Bretano et.al., 1997; Lester et.al., 2002; Thorne 
et.al., 2002; Evangeli & Kagee, 2016). Consequently, they defer disclosure as long as possible to protect 
the child. In their study with caregivers of HIV-infected children six years and older in Thailand, researchers 
found that 12.7% of caregivers who had not disclosed to their children were afraid that their children would 
be discriminated against, while 53.4% feared negative emotional consequences like distress, depression, 
anxiety and isolation (Oberdorfer et al., 2006).  
 
Guilt, fear of the consequences of disclosure like shame, alienation, and stigma result in parents and 
caregivers trying to delay disclosure as long as possible (Abebe & Teferra, 2012; Kenu et al., 2014). Parents 
and caregivers fear that if they disclose the HIV status to children, they could tell others, resulting in 
discrimination, alienation, and social exclusion (Kenu et al., 2014). The consequences of delayed or non-
disclosure include poor compliance, psychological distress and suicide (Lesch et al., 2007; Harper et al., 
2014). Caregivers and health providers often feel inadequately prepared to disclose to children and 
interventions for caregivers and staff that take into account personal processes, subjective experiences along 
with compelling cultural and social influences in the disclosure process are essential in paediatric HIV care 
(Lawan et al., 2016). Where caregivers did not disclose to children, adherence depends on the caregiver or 




medication is reportedly accomplished through direct observation, threats, bribes or forceful means like 
verbal or physical abuse (Bikaako-Kajura et al., 2006). Research findings suggest that children and 
adolescents living with perinatally acquired HIV infection have higher rates of psychiatric co-morbidities 
than their uninfected counterparts (Midtbø, Shirima, Skovdal, & Daniel, 2012). Health providers caring for 
HIV-infected children at Red Cross Children’s Hospital in Cape Town explained that this is one of the most 
significant challenges they face. They explained that children often realised that they have HIV and then 
do not know how to cope as they feel that their parents need to be protected (Conversation with professional 
nurses, June 2009).  
 
Disclosure processes and models 
Although the need for disclosure is understood, there are diverse opinions about when, how, how much, 
and who should disclose (Abebe & Teferra, 2012; Lesch et al., 2007). The American Academy of Pediatrics 
(AAP) and WHO encourage HIV disclosure to school-aged children and younger children (American 
Academy of Pediatrics [AAP], 1999; WHO, 2011). In preparation for full disclosure, continuous, 
developmentally oriented approach, to accommodate cognitive skills and emotional maturity is 
recommended (Abebe & Teferra, 2012; Gyamfi et al., 2017; Kenu et al., 2014; WHO, 2011). In their review 
of disclosure practices and processes Lesch et al. (2007) note that open communication between parents, 
caregivers and children is the exception rather than the rule. They advise that naming the disease may be 
less effective in helping children to cope than providing them with age-appropriate information and 
explanations that could help them understand and make meaning of their illness-related experiences (Lesch 
et al., 2007). Moreover, it is critically important that children be allowed to ask questions, and that their 
question be answered honestly. 
 
A family-oriented approach allows HIV-infected children to be viewed and cared for as a comprehensive 




2007). Comprehensive, integrated, family-centred services could potentially provide HIV-infected children 
and adolescents and their families with support and guidance throughout the disclosure process (Lawan et 
al., 2016; Lesch et al., 2007).   
 
HIV disclosure prevalence 
HIV disclosure prevalence appears to be associated with contextual factors. Disclosure resources and 
procedures include having a disclosure protocol, disclosure counselling, and disclosure training for staff 
(Arrivé et al., 2018). In a retrospective, longitudinal record review of adolescents living with HIV (ALHIV) 
in Kericho, Kenya the results indicated an improved mean CD4 count associated with younger age of 
disclosure (Montalto et al., 2017). The mean disclosure age was found to be 12.34 years (ranging from 
9.21–17.05). In an online site assessment survey conducted across HIV care and treatment clinics caring 
for children within the International Epidemiology Databases to Evaluate AIDS (IeDEA) cohort 
consortium, 80% of adolescents knew their HIV status by 14 years of age (IQR: 75-80%). The survey found 
that disclosure counselling was provided by counsellors (88% of sites), nurses (78%), physicians (76%), 
social workers (69%), or other clinicians (66%) (Arrivé et al., 2018). This shows a distinct improvement in 
disclosure practices compared to earlier research conducted by Vreeman et al. (2013) in which only two of 
the 120 parents and caregivers had disclosed the HIV status to the child, and only 16 (33%) of 48 
participants whose children were old enough to be disclosed to actually disclosed the child’s HIV status.  
 
In a cross-sectional mixed methods study conducted in Tanzania with 334 caregivers of HIV positive 
children, 32.6 % of caregivers disclosed the HIV status to HIV-infected children. Disclosure practices 
included the use of direct, third-party, and event-driven approaches as well as the use of drawings of a 
bad person and a policeman to accomplish the HIV disclosure event (Nzota et al., 2015). HIV-disclosure 




al., 2015). In the current study, children were not directly interviewed regarding their responses to HIV 
disclosure because they are considered to be a vulnerable population. 
2.8. Summary 
The literature review reflects differing perspectives on disclosure, and that children have little control over 
who, how, and when they are informed of the HIV status. Studies have highlighted the challenges and 
reluctance of parents and caregivers to disclose, which indicates an imperative for family-centred care, and 
the integration of disclosure support measures into routine paediatric HIV care (Lesch et al., 2017; Kenu et 
al., 2014; Gyamfi et al., 2017; Lawan et al., 2016). In the South African context disclosure is hampered by 
factors that could potentially have a negative impact on the lives of children, their families, and their social 
support networks. Non-disclosure is often driven by the desire to protect children and families from 
discrimination, social exclusion, limiting social opportunities, and lack of support (Harper et al., 2014; 
Smith et al., 2008; Stuber et al., 2008).  
 
The potential benefits of disclosure include improved understanding of health status, improved medication 
adherence, retention in care, improved self-esteem, and a reduction in anxiety, depression, and stress 
(Midtbø et al., 2012). Although HIV disclosure is pivotal in accessing care, emotional support, and 
improved retention in care, perceived risks could overshadow potential benefits, resulting in social 
isolation, poor access to care, and poor health outcomes (Vaz et al., 2011; Vreeman et al., 2013). Positive 
disclosure outcomes include better understanding of their health status, cooperation with medical regimens, 
improved adherence, improved utilisation of clinical support services, retention in care, fewer behavioural 
difficulties, establishing trust, and improved communication of fears and anxiety (Lawan et al., 2016). 
This study could contribute to improved understanding and insight into the factors that facilitate or hinder 
disclosure could facilitate the delivery of interventions and support strategies that could assist caregivers in 




understand their health status, what to expect with regard to treatments and tests, and how to address 



























CHAPTER THREE: METHODOLOGY 
This chapter presents the research procedures, including data collection, analyses, and ethical 
considerations relevant to the study. 
 
3.1. Methodology  
The study explores disclosure experiences of mothers of HIV-infected children attending Red Cross War 
Memorial Children’s Hospital (RHX) in Cape Town, South Africa. A mixed-method research design was 
undertaken. The choice was made in order to allow a deeper understanding of disclosure practices than 
could be achieved with a single data collection method (Cresswell, 2014). We conducted a cross-sectional, 
mainly qualitative, descriptive study involving explanatory open-ended interview questions. The qualitative 
portion was anchored on a quantitative component that was used to define characteristics of the study 
cohort. The quantitative component of the study was developed to allow the researcher to explore important 
cohort characteristics that informed aspects of the disclosure experience. This was important to explore the 
complex phenomenon of disclosure to an HIV-infected child that survey questions do not allow for. 
Additional follow-up questions allowed a fuller exploration of participant experiences. The qualitative 
semi-structured interview explored caregiver’s perceptions and experiences with disclosure to HIV-
infected children receiving care as well as explore HIV-infected caregiver perceptions about their children’s 
understanding about their health status and experiences with disclosure. Quantitative data collected 
provided a response to general disclosure trends in children receiving. 
3.2. Study site  
Red Cross War Memorial Children’s Hospital in Cape Town, South Africa provides comprehensive 
treatment that includes diagnostic services, counselling, management of opportunistic infections and 
community-based care to an estimated 303 children with a positive serostatus. The hospital is viewed as a 
centre of excellence in South Africa as well as on the African continent. It has academic links with the 




comprehensive paediatric services with the full range of sub-specialties at secondary, tertiary and 
quaternary levels of care (Western Cape Government [WCG], 2016). It services the Cape Metro Region as 
a regional centre and also as a tertiary medical centre for the Western Cape Province (WCP) (Van As et al., 
2004). Highly trained health professionals deliver specialist care to children who are referred from 
hospitals, clinics and smaller hospitals from the nine provinces of SA. It is a primary referral hospital, 
receiving patients from clinics, community health centres and secondary hospitals. The hospital started 
treating children with ART in 2002 with full roll-out in 2004. Children initiated on ART are referred down 
to community health centres once they are stable and remain in care (Dr J. Nuttal, personal communication, 
2013). 
 
3.3. Study sample  
A sample of participants was selected from parents and caregivers whose children are enrolled for treatment 
at the Infectious Diseases Clinic (IDC) at RXH. Currently there are 303 children in the ARV programme. 
The minimum sample required for the study is n=100. This sample size to estimate the disclosure rate of 
HIV status is based on a previous study (Mahkloko & Madiba, 2012) of 40%, using a precision of 10% 
around the 95% confidence interval.  
Usually the sample size for qualitative data is determined by the depth of information emerging from 
interviews and the point at which theoretical saturation occurs, i.e. the point at which no new information 
is forthcoming from additional interviews. This remains a tricky aspect of qualitative research as no 
guidelines or tests for estimating the adequacy of the sample size exists (Morse as cited in Guest, Bunce & 
Johnson 2006). The sampling strategy aimed to ensure that the views and experiences are diverse and 
representative of the study population. Given the small sample size, it may not be possible to draw 
generalisable conclusions from this study. However, this study could yield important insights as a basis for 
a more comprehensive study. All participants who consented to participate in the research, regardless of the age 




3.4. Inclusion and exclusion criteria  
Parents and caregivers were eligible for participation if they were the primary or secondary carer of children 
with a known HIV-positive serostatus (that is children who had an HIV + serostatus confirmed by 
appropriate diagnostic tests). Parents and caregivers whose children were recently diagnosed (that is who 
were visiting the clinic for the first or second time) were not be invited to participate in the study as they 
may still require a period of adjustment to the child’s HIV status.  
 
3.5. Data collection 
Interviews are used in research to develop insight into the experiences, perspectives, processes, behaviour 
of social phenomena (Hays & Singh, 2012). If well designed, interviews can be useful in facilitating 
dialogue between the interviewer and participant that allows participants to share what is important and 
meaningful to them, in their own words (Hays & Singh, 2012). Interviews were conducted with parents and 
caregivers to determine whether they had disclosed to the child, at what age they disclosed, their perceptions 
of the child’s and family members’ response, and what their perceived consequences of disclosure are. 
Additionally, caregivers’ fears prior to disclosure, their disclosure strategy and whether what they feared 
actually happened were explored. (See Annexure B: Caregiver Interview Schedule). 
The aim of the interview was to construct an interaction between the researcher and the interviewee in a 
manner that would facilitate an open and rich exchange (Hays and Singh, 2012).  In this research the 
researcher was interested in exploring the beliefs, experience and meaning participants ascribe to disclosing 
an HIV status to the child. Interviews are valued as a technique for generating normative accounts about 
disclosure, or non-disclosure. A structured interview protocol was administered to participants. Questions 
were developed so that it catered as comprehensively as possible to participant experiences of HIV 
disclosure (Hays & Singh, 2012).  




The time-frame for the study was reliant on clinic-attendance. The data-collection period will extended 
April to October 2014. 
 
3.7. Language and communication 
Paediatric patients and the parents attending RXH may be either English-, Afrikaans- or Xhosa-speaking. 
Recruitment materials, screening tools, consent forms and interviews were translated into Xhosa and 
Afrikaans (and back-translated to ensure their accuracy). Similarly, all interview sessions were conducted 
in Xhosa or Afrikaans where appropriate. Fieldworkers fluent in each of the local languages ensured that 
all communication was conducted in the mother-tongue of the patient and caregiver. Most participants 
chose to be interviewed in English. Where participants were interviewed in Xhosa, the interviewer 
transcribed and translated the information on the same day so that she would not lose any of the detail. 
Transcriptions and translations were checked by a 2nd Xhosa-speaking research assistant.  
 
3.8. Researcher and fieldworkers 
The potential disadvantage of interviews is that participants may want to give what they consider to be the 
right answers (Hays & Singh, 2012). The researcher and research assistants went through a process of 
training to learn how to establish rapport, how to respect participants, and to understand when participants 
felt uncomfortable and how to ask potentially intrusive questions. The researcher has 15 years’ experience 
working as a counselor on a residential camp programme in California for HIV+ children and has been 
conducting day outings and a residential camp programme in Cape Town for children attending HIV clinics 
since July 2005. Three fieldworkers who had worked on the day outing and residential camp programme 
were trained for data collection. One of the fieldworkers is a Xhosa-speaking male who has been working 
as a counselor with children for seven years. A second fieldworker is a mother living with HIV who is 
employed as a coordinator of a project focused on promoting PMTCT uptake and compliance. The third 




spearheaded the psychosocial intervention for counselors working with mothers living with HIV in clinics 
throughout South Africa.  
An experienced social worker (currently a PhD candidate) will be consulted throughout the study to 
reflect on participant experiences. 
 
3.9. Pilot study 
The data collection instrument was pilot-tested with nine participants at a different hospital. The purpose 
of pilot-testing is to prepare the researcher and assistants for their role, and to test whether participants 
understand the questions in the same way. Pilot testing allowed the researcher to determine the average 
time it would take to conduct the interviews, and to find out which questions made participants feel 
uncomfortable. The researcher made sure that the interview questionnaire was pilot-tested on people who 
represented participants who were likely to be recruited into the study from RXH, and that the interview 
was conducted in each language three times. Each participant was asked which questions they experienced 
as being difficult, and whether the questions were relevant to their experience. Participants were asked 
whether any questions were not culturally appropriate. After the pilot testing was done the researcher, 
assistants and supervisor reflected on the feedback and experience with pilot-testing the instrument. 
Alternative wording was developed for the Afrikaans and Xhosa versions.  
 
3.10. Analysis 
Quantitative analysis: Data was entered into an Excel spreadsheet and the analysis was conducted using 
STATA version 12. Descriptive statistics were examined in relation to the qualitative experiences of 
participants. Percentages have been used to depict proportions of individuals while means with standard 
deviation(SD) or medians with interquartile ranges (IQR) summarise all continuous variables. 
Qualitative analysis: The section of the interview that yielded qualitative information was audiotaped and 




several stages in the data analysis, specifically the four stages proposed by Heath & Cowley (2003).  
meaning was generated from participants’ perspectives through a process of induction, followed by 
empirical generalisations derived from the literature, and theorising about the meaning perceived by the 
researcher Hays and Singh, 2012). Analysis started with each interview as it was being conducted, and 
continued throughout the transcription of each interview (Hays & Singh, 2012). The data reduction process 
involved reading without judgement first, followed by a process of organising, segmenting, and analysing 
the text. In the first stage, the researcher and research assistants categorised words and text that were similar, 
a process known as coding (Hays & Singh, 2012). Coding is helpful and necessary as it guides theory 
formulation. Codes were merged into categories, and the coding process flowed into thematic analysis in 
which broad themes were identified and coded. Broad categories were refined and the data was reviewed 
to identify relationships in the data. This was followed by an expansion of emerging frameworks and 
making comparisons. During this stage diagrams, memos and graphic representation of relationships in the 
data were integrated into an analytical framework that proved beneficial for developing an understanding 
about what was being revealed in the data in relation to what is already known (Charmaz, 2006). In this 
regard, a data analysis log was maintained so that new ideas were tested and relationships re-examined 
through a process of checking and rechecking. In the final stage, the researcher theorised about the insights 
gained from the data by integrating the memos and data from the log analysis so that it made (Dasterdi, 
Olson, & Ogilvie, 2012). Emerging themes were examined in relation to published literature. Through this 
process the researcher was able to present the collective analysis of participants’ experience with HIV 
disclosure. 
 
3.11. Trustworthiness and reflexivity 
Conversations with parents /caregivers about HIV disclosure can be rather daunting; hence participants 
may be inclined to be reticent in their responses. It is very important that the researcher establish a 




that their right to privacy will be protected at all times. One strategy for alleviating anxiety related to being 
exposed would be to have participants select a pseudonym known only to the researcher and participant. 
Participants will be informed that their name will not be linked to the interview and that their names will 
not be mentioned in any reports or publications emerging from this study (Coombs & Smith, 2003).  
Furthermore, since researchers cannot always claim to be bias-free, the researcher reflected on and 
acknowledged and attempted to analyse his own preconceptions, biases and beliefs in the context of the 
research. Reflexivity in research is essential as the researcher creates new knowledge through respectful 
engagement with study participants (Ulin, Robinson, & Tolley, 2005). Research findings are constructed 
through the meaning and interpretation of the researcher and study participants, which is informed by the 
effects of age, race, class, gender, and the broader social context (Hays and Singh, 2012; Ulin et al., 2005). 
Even though the researcher has raised and disclosed to a child who was HIV-infected, it cannot be assumed 
that this facilitated sharing less socially acceptable views. Although the similarity might have been an 
advantage for establishing rapport, it does not necessarily suggest shared interpretations and meanings. The 
researcher was cognisant that this could potentially influence his perceptions; hence a debriefing session 
was held with the assistant researchers after each day of interviewing (Hays & Singh, 2012). He was also 
aware of the social and power dynamics of being a male interviewing predominantly female participants 
(Hays & Singh, 2012). The benefits of keeping a diary and field notes throughout the research process is 
twofold: it allowed the researcher to have a clear audit trail, and it allowed the researcher to reflect on his 
own subjectivity and influence over study participants (Hays & Singh, 2012; Ulin et al., 2005). Davies and 
Dodd (2002) are emphatic about the significance of informal, anecdotal and experiential contributions to 
legitimate knowledge. Likewise, this study places value on the reflective self-examination of the 
researchers’ own ideas as an integral part of the research process (Green & Thorogood 2009). 
Credibility 
Credibility relates to the extent to which the research explored what it set to examine (Hays and Singh, 




present the findings as close to the lived realities of participants as possible.  Strategies for developing 
credibility include prolonged engagement with study participants and an understanding of the social context 
(Hays & Singh, 2012; Ulin et al., 2005). Peer debriefing was used in this study to improve reflexivity, and 
to tests the researcher’s interpretation of participant experiences.  
Transferability 
The researcher provided a detailed description of the research process to allow clinicians and researchers 
in other contexts to make decisions about the extent to which the findings are relevant in other contexts 
(Hays & Singh, 2012).  
Dependability 
Dependability is an evaluation of the quality of research procedures (Ulin et al., 2005). Dependability in 
this study relates to the extent to which the research team agreed with the study findings. audit trail entails 
maintaining comprehensive notes related to the background of the data and the rationale for all 
methodological decisions made during the processes. 
Confirmability  
Confirmability is similar to dependability and relates to the extent to which the findings of this study are 
genuine reflections of the experiences of research participants. The data analysis process was an iterative, 
consultative process. Interpretive discrepancies were resolved through consensus (Ulin et al., 2005). No 
decisions had to be deferred to another, experienced qualitative researcher for resolution.  
Authenticity 
The researcher took great care in representing participant perspectives authentically. 
Coherence 
Interview transcripts were reviewed by two independent and experienced qualitative researchers. A third 
researcher will be consulted to resolve interpretive discrepancies. 
A member check will be done with a randomly selected group of participants at the end of the study to 




study reflects consistency and care in the application of research practices which are cognisant of the 
partiality and limits of our research findings.  
 
To maintain rigour in this research, the researcher provides a clear account of procedures used in the study 
so that there is an audit trail for other reviewers to follow. Interpretations will be supported by evidence 
from the interview transcripts. The researcher will pay particular attention to information emerging from 
all research methods employed and will compare the findings to other studies (Green & Thorogood 2009) 
 
Hawthorne effect 
The Hawthorne effect refers to the behaviors of participants in response to being researched. All research 
methods have at least some effect on the responses of participants and qualitative researchers prepare for 
this factor by explaining the relevance of the research and the way in which it will be used, by reassuring 
participants of confidentiality and that their responses will be used anonymously (Stevenson et al., 2000). 
The most important techniques involve establishing an ethical trust relationship and helping participants to 
feel relaxed. Understanding the multi-faceted, complex and paradoxical features of intense personal 
processes and choices is best understood from the perspective of the participant, requiring the full 
understanding and commitment of both the researcher and the participant (Coombs & Smith, 2003). This 
research is governed by respect for the personal perspectives, opinions and experiences of both the 
participant and the researcher, engaged in a partnership to better understand the forces that shape caregivers’ 
HIV disclosure or non-disclosure choices. 
 
3.12. Ethical considerations 
This research was conducted in accordance with the principles of good clinical practice, and participant 
protects described in the Belmont Report (1979), The Helsinki Declaration (2013), and the international 




Medical Sciences [CIOMS], 2016). Ethical clearance was obtained from the Research Ethics Committee 
of the Health Science Faculty at the University of Cape Town. Participants were fully informed of the study 
and their rights as study participants were respected. To respect participant autonomy, the researcher 
explained the purpose of the research and provided each participant with a detailed information sheet. Every 
effort will be made to obtain informed consent hence the consent form will be issued to each participant to 
sign only after the research purpose and procedures have been explained simply and clearly (Belmont 
Report, 1979; The Nuremberg Code, 1949). The informed consent procedure involved making an 
assessment about the eligibility of the participant for this study. If the participant meets the inclusion criteria 
for this study, she/he will be approached for recruitment as a study participant. Informed consent was 
obtained by explaining the purpose of the research, as well as the research procedures in the participant’s 
mother-tongue. All conversations with participants were conducted in a private room to ensure privacy. 
Every effort was made to maintain the strictest confidentiality and the trained interviewer who assisted with 
data collection was informed about the obligation of confidentiality. Additionally, the researcher and 
research assistant assessed the understanding of the content and process of the consent form with each 
participant before the consent form was signed. Participants were informed that their participation was 
voluntary, and that they could withdraw from the study at any time if they chose, without consequence. 
Participant anonymity was assured by allocating a number to each participant. The name and number is 
known only to the researcher and the research supervisors.  
 
All information, including written notes, transcriptions and data analysis records were stored on a password-
protected computer to which only the researcher has access. All notes, interviews and tape recordings were 
stored in a locked cabinet in the researcher’s office. Only the investigator of this study and the research 
assistant had access to this information. Electronically stored data was password protected on a computer 
to which only the investigator has access. Data will be deleted after 5 years. Data analysis or published data 




If the case of participants who were unable to read and write, the researcher explained the purpose of the 
study and that she/he meets the inclusion requirements.  If she/he expressed an interest to participate in the 
study, the content of the IC will be explained.  Subsequent to agreeing to participate, an impartial witness 
(someone of the participant’s approval) will ask her/him whether she understands the study and IC.  If 
she/he agrees, the researcher and witness will sign the IC and the subject will provide a right thumb print 
on the appropriate area on the document. If the participant is reluctant to have a thumb print, she/he can 
mark with an ‘X’ and this will be recorded on the consent form.             
 
3.13. Risks and benefits to participants  
Discussing issues of disclosure and non-disclosure could potentially increase emotional distress for 
caregivers and children alike. The researcher collaborated with social workers and a clinical psychologist 
to mediate the effects of any adverse experiences. By sharing opinions and experiences about HIV 
disclosure in children, participants were provided the opportunity of gaining increased self-knowledge and 
self-confidence about talking to children about their health. 
 
3.14. Clinical significance 
Insight into the factors that facilitate or hinder disclosure could facilitate the delivery of interventions and 
support strategies that could assist caregivers in delivering developmentally and culturally appropriate 
communication strategies that will help children understand their health status, what to expect with regard 









CHAPTER FOUR: RESULTS 
This chapter presents the results of the study. Quantitative analysis is followed by explanatory qualitative 
analysis.  
 
4.1. Demographic characteristics 
A summary of the main demographic characteristics of study participants is presented in Table 1. The study 
sample included 102 participants, ranging in age from 16 years to 71 years. The sample included 73 mothers 
(72%), six fathers (6%), 11 foster-mothers (11%), and 12 caregivers or grandmothers (12%).  Participants 
included 65 (58%) who were unemployed and 26 (23%) participants who were formally employed. Of the 
102 participants, 65 (64%) received a social grant, 3 (33%) received no grant, and three were unclear. 
Regarding living situation, 35 (34%) participants lived in shacks, 37 (36%) owned a house or flat, 9 (9%) 
rented a house or flat, and 15 (15%) shared a house or flat with others (6 were unclear).  
Table 1: Participant demographics 
Variable Frequency Percent 
Relationship to child   
Mother 73 71.6 
Father 6 5.9 
Foster-mother 11 10.8 
Caregiver/Grandmother 12 11.8 
Education 
Primary level  23 22.8 
Secondary level 57 56.4 
Tertiary level 4 3.9 
Employment status 
Formal employment 23 22.8 
Unemployed 57 56.4 
Casual employment 11 10.9 
Self-employed 7 6.9 
Full-time housewife 1 0.9 
Student 1 0.9 
Other 1 0.9 
Grant support 
Receive grants 65 64.4 
Do not receive grant 
support 
33 32.7 
Unclear N/A 3 3.0 
Living situation 







House/Flat owner 37 36.3 
House/flat renting 9 8.8 
House/flat sharing 15 14.7 
Unclear 6 5.9 
 
 
The median age of the participants’ children was 4 (IQR 2-8) years and ranged from five months to 16 






































4.2. HIV Test 
 
In total, 94 participants (94%) had an HIV test done, four were not tested (4%), and two (2%) stated they 
did not need a test. 
 
4.3. Disclosure to the child 
Disclosure to the child is presented in Table 2 below. Of the 102 participants 86 had not disclosed to the 
child (48 children were not old enough to be disclosed to) and 16 children had been disclosed to.  
The clinic in which the children were being followed up has adopted a tool for step by step disclosure to 
the child (Eley, Nuttal, & Apolles, 2011).  
 
Table 2: Disclosure to the child 
Disclosed to child Frequency % 
Yes 16 84.31 
No  86 15.69 
Total 102 100.00 
 
Table 3 illustrates disclosure in relation to the child’s age. In the study sample one child aged 5 to 7 years 
was disclosed to, seven children 8 to 11 years were told their HIV status, and eight children older than 11 
years had their status disclosed.  In terms of relationship to the child, nine mothers, two fathers, two 
foster-mothers, and three caregivers or grandmothers disclosed to the child. Table 4 presents disclosure in 
relation to the relationship with the child. 











5 – 7 years 22(96) 1(4) 23 
8-11 years 7(50) 7(50) 14 
>11 years 3(27) 8(73) 11 












Participants were asked about their perspectives about the child’s readiness for disclosure; qualitative 
responses are presented below. 
 
Caregiver perceptions of the child’s readiness for disclosure 
 
Several participants stated that the child readiness for disclosure would depend on their ability to  
understand, although perspectives differed regarding the age and timing of disclosure-readiness.  In  
general, ages 10 to 12 years were perceived as a good time to disclose as their level of awareness of HIV  
would be developed and they were likely to understand their illness. One 32 year old mother, whose  
boyfriend was HIV-negative, explained that her four year old son was too young to understand  
what HIV is, and that the boy had not questioned why he was taking medication stated: 
“I will tell him when he is 11 years old, when he can completely understand. I give him his tablets 
and he does not ask me questions because he trusts me”. 
Age was the most commonly stated reason for non-disclosure, the main worry being that the child might 
be too young to understand what it meant to be HIV-infected. A 48 year old foster mother felt that five 
years of age was too young to disclose to a child, and stated: 
 “If I tell him that early he might think he is going to die, because he will not understand properly”. 
 
A 28-year-old mother of two infants, of whom only one is HIV-infected, disclosed to the child at 6 years 
of age, saying: 
Relationship to child Disclosed to child Total 
No Yes 
Mother 20(69) 9(31) 29 
Father 3(60.00) 2(40) 5 
Foster mother 5(71.4) 2(29) 7 
Caregiver/Grandmother 4(57.1) 3(42.9) 7 




“I also asked her. When you drink this pill do you know it’s for what? She says it’s for the heart. 
Then I sit her and explain that she has HIV. She will respond by saying hay wena.  Even when her 
friend asked her what are the pills for. She tells them it’s for the heart” 
A 54 year old mother of four children disclosed to her only HIV-infected child at 11 years of age with the 
help of health staff: 
‘I asked a doctor who arranged with a social worker to speak to her. When she asked me at five 
years of age I used to say to her that she has to take them for her asthma”. 
 
4.4. Disclosure intention 
 
In this study 48 participants had disclosure intentions compared to 54 who did not, and only 16 
participants actually disclosed to the children who were at an age in which disclosure should have been 
done versus those in which it was actually done (presented in Table 5 below). 
 
Table 5: Disclosure intention vs disclosure to children who were at an age in which disclosure    
should have been done 
 
Intention to disclose Disclosed to child Total 
No Yes 
No 54 (100) 0 54 
Yes 32(66.7) 16(33.3) 48 
Total 86(84.3) 16(15.7) 102 
 
Participant reasons for disclosure or disclosure delay are presented below. Of the 16 who disclosed, on 
average disclosure took place when the child was 8.9 (SD 2.3) years. If five years was regarded as the 
earliest age of possible disclosure, this indicated an average delay of 3.9 (SD 2.3) years. 
  
Reasons for disclosure or disclosure delay 
 
Several caregivers expressed concern about how to disclose to their children, and expressed anxiety 




“He don want to take he tired why only him he taking the other children not taking so why he take 
this medicine I say I’m also taking you must taking because you are HIV.  He say angry who gave 
me HIV?”  
Guilt and shame emerged as a significant concern and cause for disclosure delay, as expressed by 37 year 
old mother of two children whose second child was HIV-infected: 
“I feel very bad and ashamed that I have given my child this disease that makes people to talk and 
laugh at us behind our backs. I want my child to be proud of me, to be proud of herself. This child 
will have to live with my shame for the rest of her life if I tell I gave you HIV. She will think I am 
a bad person who has many boyfriends and should not be her mum”. 
Participants who were reluctant to disclose to their children feared exposing their child to discrimination 
and stigma. A 37-year-old single mother of three children stated: 
“Because he was losing weight nê, and another child he talked to him and said I don’t want to play 
with you. Because you’re not right. He came like this he came to cry. My mother, another child 
say I don’t want to play with me”. 
A biological mother of three children stated: 
“Yes I’m afraid she will not understand and tell other people about her status. 
Several participants delayed disclosure which they perceived as protecting the child. This was expressed 
by a 31-year-old father who stated: 
“I feel ok not to tell her because I’m only protecting her against the people who will discriminate 
against her”.  
The fear of stigmatisation extended beyond the instinct to protect the child to fears related to exposing the 
family to stigmatisation through the child’s accidental disclosure. A 48-year-old mother of three children, 
of whom only the last child is HIV-infected, delayed disclosing until the child was 13 years of age 




“Because I thought he was going to be angry with me. He is the only child that has the virus. 
I was afraid he was going to tell his friends. Because they will not want to be his friends 
anymore”. 
Some participants expressed anxiety about the possibility that the child might learn about their health 
status from others.  
“I had to tell her at 5 years, because we were at the hospital one day sitting in the foyer at the ear 
nose and throat clinic, when a mother gave her child his medication. She observed that the child 
was taking the same medication as her. She then told the lady that she takes the same medication. 
The lady then asked her whether she has AIDS too”.  
 
Anxiety about disclosure by others before the parent had told the child was mentioned, as expressed by a 
mother who noticed that the child started showing signs associated with HIV infection: 
“Because there was another child he was sick. And she said to my child, no man you must eat 
your tablets. Look see the photo here. Look at where I was before but now I’m big”.   
In some instances, disclosure was triggered by the child asking questions about their health status,  
hospital attendance, and medication. A mother who disclosed the HIV status to the child at 10 years of  
age reported: 
“… initially he wanted to know why he was taking the medication, so I explained to him that he’s 
taking the medication because of the virus and there’s no cure and because he must use it to take 
the medication for the rest of his life and then I tried to reassure him”. 
 
A few participants were of the opinion that HIV awareness was increasing, at school and through the  
media, and children had the right to know their HIV status so that they could be empowered to disclose  





“Because of his understanding about the disease he is now helping the other foster children who 
come to our home to make sure they take their pills. His sisters, brother and friends also remind 
him to take his pills”. 
A 43-year-old father disclosed to the child at 12 years of age, stating: 
“I told him immediately when we found out. It is better to tell your child immediately or at an 
early age because they will question on why they have to take the medication”. 
Participants expressed an awareness of shame and self-blame that children could experience when they 
discover that they are HIV-infected. A 43-year-old mother who disclosed to the child immediately he was 
diagnosed at 12 years of age who expressed feeling shame about his illness: 
“That it is not the end of the world it is not a death sentence. You did not stand on a mountain to 
call HIV to you. There is hope because of medication and medical science”. 
 
4.5. Prevention-of-mother-to-child transmission of HIV adherence and disclosure to the child 
 
Of the 69 mothers who were enrolled into the PMTCT programme while pregnant, 48 were adherent and 
21 were not. A total of 43 PMTCT adherent mothers did not disclose, while 5 disclosed to the child. In 
total, 21 mothers were PMTCT non-adherent, 16 did not disclose and 5 disclosed to the child. This data 
must be understood in relation to the number of children who were < 5years of age, hence developmentally 
may not have been ready for HIV disclosure. Table 6 illustrates the relationship between PMTCT adherence 
in relation to disclosure to the child. 
 







Disclosure to child PMTCT adherence Total 
No Yes 
No 16 (27.1) 43 (72.9) 59 
Yes 5 (50) 5 (50) 10 




4.6. Stigma and disclosure to the child 
Mothers’ experience of stigma in relation to disclosure to the child is presented in Table 7. 






4.7. Disclosure strategies 
Perspectives about the best way to disclose varied among participants. Several participants shared the 
perspective that it is the child’s right to know about their illness, and that disclosure should be done as 
soon as the diagnosis is known. A 54-year-old single mother who disclosed to her son at five years of age, 
believed that she had to be honest with her son from the beginning stated: 
“you see you drink these tablets, your mother has HIV and you have HIV and this tablets is for 
your life. You must know about HIV. I’m going to tell him if he was 6 or 7 years and my son he 
will not like if I did not tell him that he has HIV. I always am honest with him yes. 
He will be angry if he is older and if I lie to him”. 
 
Another perspective was that disclosure should be a gradual process involving several conversations, 
preferably initiated by questions from the child. One mother of three children, who initially tested 
negative for HIV, whose infant was often ill and was diagnosed with HIV after he was hospitalised at 
three years of age as a result of Tuberculosis (TB), disclosed to her son gradually, and introduced the term 
HIV when he was 10 years old: 
“I told him bit by bit. Sometimes …. he said to me why my mother take this tablet? I look to him, 
I told him if you don’t take this tablet you gonna die. Because of what? You see you and me too, I 
am eating my tablet. Because you and I have HIV. If you don’t eat your tablets you gonna die”. 
Disclosure to child Stigma Total 
No Yes 
No 59 (86.8) 9 (13.2) 68 
Yes 8 (80) 2 (20) 10 




Some participants confessed to telling children that they have other health problems before having the 
courage to tell the child the truth, as expressed by a single mother: 
“My son you have asked me many times why you have to take these pills. 
I did not tell you the truth at that time because I thought you were too young and will not 
understand. Today I will tell you the truth. You are living with HIV that is why you have to take 
the pills, but you must not be afraid because you know about HIV from the school. If you take the 
pills and attend the clinic you can live a normal life”. 
Complete disclosure, in which the child is told about their illness, the term HIV is used, and the role of 
ARVs in a life-long chronic illness is discussed was mentioned by a 37-year-old single mother disclosed 
to her daughter at eight years of age: 
 “I told her that she has a blood problem and it is called HIV.I told her because she 
watches programmes on TV and she always says that she does not want to have that sickness. 
Before she was eight she thought that she was taking the medication for TB and that by taking the 
medication it will prevent her from getting the virus. Because she was too young to understand”. 
 
4.8. Disclosure support 
Relationships with and support derived from health providers contributed to a sense of safety and 
confidence in initiating conversations with children about their HIV status.  
A mother who had disclosed to her child recognised the important role of support groups in assisting with 
disclosure to the child: 
“So if we have a group here with the social worker and the Mums sit together and talk and they 
help you in the group but also one-on-one when you see the sister would that help you, if the sister 
helped you to tell the child? Would that work for you?” 
A mother who disclosed to her son immediately when he was diagnosed after admission to hospital at 12 




“When we had counselling we told him, that he is HIV positive, and told him that if he takes he’s 
medication he will live long and that other people will give him wrong information. 
A 47-year-old foster mother of five children, two of whom are HIV-infected, and who disclosed to the 
boy at nine years, stated: 
“I told him that he has aids and need to be on medication for the rest of his life”. 
No he has no fears because he had knowledge about HIV because of the exposure 
 and support he has in the community support group”.  
 
4.9. Disclosure advice to other parents and caregivers of HIV-infected children 
Participants were asked what disclosure advice they would provide to other parents or caregivers of HIV-
infected children. Understanding the disease, accepting that it is a lifelong chronic condition that requires 
medication, accessing support, staying in care and helping children to understand and accept their health 
status were important messages participants shared.  
A 39-year-old mother of two, of which only one is HIV-infected, offered the following advice: 
“I will tell them not to be afraid because the medication that helps. There are also group 
discussions that is like a support structure”. 
A 34-year-old caregiver offered the following advice to other mothers: 
“I will tell them they have to support their children, its ok they must just make sure that they take 
their pills every time and go for regular check up to the clinic. They must also not tell everyone , 
they must tell people they can trust because they can support you”. 
A 34-year-old mother of two children stated: 
“HIV does not kill someone, they kill themselves. Also give your children their medication. Do 






CHAPTER FIVE: DISCUSSION 
Increased access to paediatric ART has substantively improved child and adolescent health outcomes, 
necessitating disclosure practices in paediatric HIV management and care (Evangeli & Kagee, 2016; 
Jemmott et al., 2015; Tadesse et al., 2015). This study was conducted with 102 parents and caregivers at a 
tertiary hospital in Cape Town delivering care to 303 HIV-infected paediatric patients. Disclosure or 
disclosure delay was associated with several factors, including the child’s age or ability to understand, 
anxiety and guilt about being blamed for infecting the child, fear of exposing the child to stigma, 
discrimination and social exclusion related to the child disclosing to others, and the hope that the child 
would be adherent if they understood their illness and the way in which the medication could improve their 
health outcomes. Similar to the findings of research conducted by Vreeman et al. (2013) in which only two 
of the 120 parents and caregivers had disclosed the HIV status to the child, only 16 (33%) of 48 participants 
whose children were old enough to be disclosed to actually disclosed the child’s HIV status. The results 
indicate that HIV-disclosure remains a challenging, emotionally-charged experience for mothers and 
caregivers. Evangeli and Kagee (2016) proposed that contextual factors affect disclosure practices. Socio-
economic factors, like employment status and living environment could influence perceived control that 
parents and caregivers perceive they have over the disclosure process. In this study 64 participants were 
unemployed, 72 received a social grant, and lived in shacks, suggesting that they had limited material 
resources. In previous studies caregivers with higher educational levels were found to be more likely to 
disclose to children (Paintstil et al., 2015; Vreeman et al., 2013). The educational level among participants 
in this suggests that most participants did not attend school when HIV was introduced into the life-skills 
curriculum at secondary level, which could have undermined their lack of confidence in sharing information 






The low disclosure rate to children five years of age and older in this study is of concern as HIV disclosure 
has benefits. In a cross-sectional study of disclosure prevalence and determinants conducted in Ghana, 
children who knew their HIV status demonstrated improvements in their understanding of HIV and the 
reason for taking medication, self-efficacy and involvement in taking ART (Kallem et al., 2011). In sub-
Saharan Africa non-disclosure remains the principal factor undermining ART adherence in children Paintsil 
et al., 2015). Although no conclusive evidence supporting the association between HIV disclosure and ART 
adherence was found in a qualitative study conducted by Vreeman et al. (2013) in Kenya, a study of 
disclosure conducted among adolescents in Thailand was associated with a CD4 count below 30% (Sirikum 
et al., 2013). A cross-sectional study conducted with HIV-infected children and adolescents in western 
Kenya by Vreeman et al. (2014) found no association between disclosure and clinical indicators. Despite 
these discrepancies, disclosure benefits like improvements in children’s physical and psychological well-
being, ART adherence, and social functioning support paediatric HIV disclosure (Kallem et al., 2011; 
Paintstil et al., 2015, WHO, 2011).  
 
The disclosure rate in a systematic review conducted by Vreeman et al. (2013), disclosure ranged between 
0% and 69.2%. In the study conducted in Ethiopia, only one third of the 137 caregivers disclosed the child’s 
HIV status (Tadesse et al., 2015). Mweemba et al. (2015) in their study of caregiver disclosure practices to 
adolescents found the disclosure rate to be 56.7%. Of the 102 participants in the current study, 48 
participants had disclosure intentions, and 54 did not, with only 16 actual disclosures to children. It is 
however important to point out that children ranged in age between five months to 16 years. Only 48 (47%) 
were old enough for disclosure to be possible which would make the disclosure rate 33%. A total of 57 
(54.81%) participants in the current study disclosed their HIV status to their romantic partner, and 47 
(45.19%) disclosed the child’s HIV status to their partner. A study conducted by Jemmott et al. (2014) that 
examined predictors of intention to disclose showed that the expectation of approval from significant others 




be closely related to the intention to disclose (Jemmott et al., 2014). This study did not explore 
communication as a determinant of disclosure practice.  
 
Disclosure to older children was more likely than younger children in this study. Ages 10 to 12 years and 
older was the preferred disclosure age, similar to the findings of the disclosure review conducted by Pinzón-
Iregui et al. (2013) in which nine studies reported older age as a disclosure predictor. Some parents and 
caregivers (54) were caring for children who were under 4 years of age, and possibly developmentally not 
ready to understand what being HIV-infected meant, 23 children were 5 to 7 years of age, 14 were 8-11 
years, and 11 were older than 11 years. The concept of “being old enough to understand” was not 
satisfactorily explained despite attempts at trying to elicit participant understanding of what it meant. The 
decision to disclose when the child was old enough to understand was a common belief expressed by 
participants in this study. In their review of HIV disclosure in relation to theories of cognitive development, 
Lesch et al. (2007) drew on Piaget’s cognitive developmental theory which proposes that children have the 
conceptual ability to understand HIV. Evangeli and Kagee (2016) examined post-intentional disclosure 
process, affect, as well as social and professional disclosure support and proposed a new model of paediatric 
disclosure decision-making.  They incorporated the child’s age, disclosure attitudes, affective and cognitive 
elements, and normative beliefs about when disclosure should be done. Apart from changing cognitive 
development, parent and caregiver concerns about adolescent risk behaviour were taken into account. 
Previous disclosure experience and openness regarding their status influence disclosure to children and 
adolescents, particularly for those parents who felt shame or guilt (Evangeli and Kagee, 2016).   
 
In this study concerns about disclosure to the child as a catalyst to the child’s potential disclosure to others, 
with subsequent negative social reactions like being the target of gossip, discrimination, and alienation was 
a strong deterrent to disclosure to the child. Being discriminated against was reported to be a barrier to 




et al., 2013; Vreeman et al., 2013). Participants in this study felt a strong need to protect their children and 
families against painful and unjust treatment, similar to the findings of the HIV disclosure study conducted 
with 298 caregivers conducted at two teaching hospitals in Ghana (Paintsil et al., 2015). 
 
Participants considered children asking questions about their illness, or refusing to take medication to 
indicate the need for disclosure. The process of deciding when a child was ready for disclosure appeared to 
be contingent on individual perceptions about whether the child was ready, or whether the child not 
knowing their HIV status could potentially undermine medication adherence. Thus caregiver readiness to 
disclose appears to have an association with perceptions about the child’s disclosure readiness, which 
correlates with the findings of the research conducted by Madiba and Mokwena (2012) and Mahloko and 
Madiba (2012) in South Africa. Even though parents might have strong disclosure intentions and a positive 
attitude, they may also experience contradictory anti-disclosure attitude based on the fear of being blamed, 
negative reactions of children, or fear about the child disclosing to others (Evangeli & Kagee, 2016).  
The low disclosure rate in this study could be related to concerns about negative reactions from the child 
that could potentially impact parent/caregiver-child relationships. Negative anticipated reactions relate to 
parent affect associated with lack of confidence about communicating the information in the right way, 
concerns that the child might not understand the information, and the child being either angry or depressed 
(Evangeli & Kagee, 2016; Paintsil et al., 2015).  
 
Disclosure support was mentioned by participants in this study, suggesting that there is a need for focused 
disclosure planning in paediatric HIV care. The findings of a group-based behavioural intervention for HIV 
–infected adolescents and youth in Chicago, New York, Miami and Memphis demonstrated stigma 
reduction related to disclosure concerns (Harper et al., 2014). The intervention included HIV-related 
information, and facilitated the development of coping skills for addressing stigma, and building healthy 




suggesting that females might need more assistance with regard to developing and maintaining healthy 
relationships (Harper et al., 2014). 
 
LIMITATIONS 
The relatively small sample size (n=102) limited statistical power to detect relations between key variables. 
As with all qualitative research, participant self-report and the fact that the researcher was perceived to be 
a health professional means that the responses could have been influenced by social desirability response 
bias. An attempt was made to mitigate this bias by explaining, during the consenting process, that all 
information would remain confidential, that participant identity would be protected, and that the insights 
from the research could be very helpful for other parents and caregivers of children living with HIV. At the 
time the study was conducted disclosure support had not been integrated into routine paediatric HIV care, 
and the children were not yet being prepared for transfer to the adolescent HIV care facility. It would be 
beneficial to conduct further research with HIV infected adolescents to explore their perceptions of 
disclosure practices of this cohort of parents and caregivers. A further limitation relates to the age of 
children which presented a barrier to disclosure. Perceptions that children were too young to understand 
the meaning and implications of being HIV-infected could have been a likely barrier to intention to disclose. 
Further studies with older adolescents could provide more insight into disclosure trends, specifically factors 
that hinder intention to disclose. Although participants were asked about the child’s response to being told about 
their HIV diagnosis, substantive information could not have gathered to answer this important question. 
 
Despite these limitations this study yielded insights into parent and caregiver experiences and 
conceptualisation of disclosure, and the factors that influence their disclosure intentions and practices. The 
findings of this study correlate with research conducted in other contexts and revealed that parents and 
caregivers need a great deal of guidance and support in disclosing an HIV status to children and adolescents. 




think strategically about how and when to disclose to children. A paediatric HIV disclosure intervention 
was developed and is being implemented at RXH, and further research on the subject of disclosure could 




























CHAPTER SIX: CONCLUSION AND RECOMMENDATIONS 
 
6.1. CONCLUSION 
This study found that parents and caregivers have to mediate complex, often interrelated challenges and 
concerns about disclosing the HIV status of children. Disclosure intentions are significantly associated with 
concerns about the right age at which to disclose, whether the child would understand, and fears related to 
guilt and blame. The study findings correlate with disclosure research conducted elsewhere in South Africa, 
other low and middle-income countries Africa, and global reviews of disclosure research. It is important 
that disclosure be understood at the individual level, with due regard for contextual factors that could affect 
disclosure determinants. Caregiver experiences, attitudes, and anticipated outcomes are important 
considerations, and are likely to change over time. Anxiety emerged as a significant part of the disclosure 
experience and is a key barrier in the transition from disclosure intention to actual disclosure. This research 
highlighted the need for disclosure support and recognises that health providers are well-positioned to 
respond to child and caregiver disclosure needs in the clinical environment. Although human resource 
challenges in the public health system are recognised, it is nonetheless important that health professionals 
expand paediatric HIV care in resource-constrained contexts in Africa to address HIV disclosure.  
 
6.2. RECOMMENDATIONS 
This research was conducted before the implementation of a tool for step by step disclosure to the child 
(Eley et al., 2011). Further studies for evaluating disclosure experiences could yield valuable information 
about the outcomes associated with the tool, as well as provide guidance for improving processes linked to 
disclosure practices. New disclosure models are emerging that take child development and caregiver 
experiences, disclosure attitudes, beliefs, and disclosure barriers into account. The findings of this research, 
and similar studies, point to the value of integrating disclosure support and planning into routine care for 




The results of the retrospective, longitudinal record review of adolescents living with HIV (ALHIV) in 
Kericho, Kenya emphasised the strategic role of counsellors, nurses, physicians, and social workers in 
facilitating disclosure (Montalto et al., 2017). This recommendation is supported by Arrivé et al. (2018) 
who found that disclosure resources and procedures like having a disclosure protocol, disclosure 
counselling, and disclosure training for staff contribute to improved disclosure practices (Arrivé et al., 
2018). Integrated, family-centred models of care need consideration at policy and programme planning 
levels.  Best practice suggests that disclosure should be incorporated into routine HIV management and 
care, starting with the development and implementation of an appropriate disclosure guideline for staff, 
followed by appropriate training for all staff involved in delivering care to children and adolescents who 
are HIV-infected.  
 
Caregivers and parents could benefit from guidance and training that could assist them in developing 
confidence in their own HIV-related knowledge, so that they are able to share relevant, appropriate 
information with children. In this regard it is important that clinical staff routinely assess what the child or 
adolescent knows about the health status, and the nature of the relationship between the caregiver and the 
child or adolescent. Age-appropriate disclosure requires specific guidance about understanding children 
and adolescents’ cognitive, emotional, and social development.  
 
Contextual factors, like adverse social circumstances merit attention, suggesting closer collaboration with, 
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 Consent Form  
 
Study purpose: 
You are invited to participate in a research project being conducted by researchers from the University of 
Cape Town. The purpose of the study is to better understand what and how caregivers communicate with 
children about their health and hospital visits. Caregivers attending S4 clinic at Red Cross War Memorial 
Children’s Hospital will be invited to participate in this study. We hope that the results of this study will 
help to improve health service delivery for children and their families. 
 
Study Procedures: 
If you decide to participate in this research study, you will be interviewed by the researcher or the research 
assistant. The interview will last no more than 30-45 minutes.  
 
The interviews will be recorded on a tape recorder so that the researcher can write down the conversation 
and is able to listen to it carefully. This will help the researcher understand clearly what the caregiver and 
child have said. The tape recording and typed pages of the interview will be kept in a locked cupboard in 
the researchers office. Only the researcher and the research assistant will have access to this information.  
 
The health staff at the hospital will not have access to this information and your participation on this study 
will not affect the care your child receives. 
 
Voluntary participation: 
Participation on this study is voluntary. You are free to refuse to answer any question. If you decide to 
participate in this study you are free to change your mind at any time and this will not affect the care you 
or the child receives.  
 
Confidentiality: 
Information will be kept confidential. The interview sheet, tape recordings and transcripts will not have 
your name on it and no information identifying you will be given to anyone. Any reports or publications 
about this study will not identify you, the child or any other participant. 
 
Possible risks: 
While you are participating in this research study, you may experience some emotional discomfort. If this 
happens and you feel that you need to speak to a counselor or social worker, you will be given the 
opportunity to do so.  
 
Possible benefits: 
You may benefit personally by talking about your experiences you could become more confident about 
talking to your child about his/her health. 
 
This study has been approved by the Research Ethics Committee at the University of Cape Town. If at any 
time, you have questions or concerns about this study, please contact  
The Principal investigator: 











I have read the above information, or it has been read to me. I have had the opportunity to ask questions 
which have been answered to my satisfaction. I hereby consent to participate voluntarily in this study.  
Name:…………………………………………………… 
Signature:…………………………      Date:……………………………. 
 
Witness name:……………………                 Signature:………………………… 
 
 
If unable to write: The content has been explained to me by the investigator or dedicated research assistant 
in my own language. 
 
Signature/thumb print:……………………      Date:……………………………. 
 








































Information Sheet Participants 
 
My name is Robert Shea and I am studying at the University of Cape Town. I am doing research with the 
parents attending the HIV clinic to understand how parents go about disclosing the HIV status to children.  
If you agree to be a part of this research, you will meet with me or one of the other researchers who will do 
an interview with you in a private room. If you would like to be interviewed in your home language, one 
of the fieldworkers who speaks your language, and who was trained to do this research, will interview you.  
 
It is very important to me in this research not to miss anything you say. So I will use a small recorder to 
record the conversation we have. I am the only person who will listen to the recording and I will keep notes 
of what we talk about.  I will not write your name on any of my notes and I will not use any names you talk 
about. I will also not tell anyone what we have talked about. Only I and the doctor who is supervising my 
research will know what we discussed, and that doctor does not work in this clinic. 
 
Please also remember that if you decide not to be a part of this research anymore, you can do that and you 
will still be treated the same by everyone. No-one will be upset or angry with you if you decide not to take 
part in this research. If you feel upset about anything we talked about, please let me or the nurses and 
doctors know so that we can let you see the social worker. You will be able to tell him or her what upset 
you. 
 
Do you have any questions now? If you ever have any questions, if there is something you do not understand 
or need me to explain to you again, please do not be afraid to ask me. I will make time to explain anything 
about this research to you as many times or whenever you need it. 
       
If you have any queries, please feel that you can contact: 
Supervisor : Dr D Cooper 
University of Cape Town 
Women’s Health Research Unit 
Tel: 021 406 6528 
 
Investigator – Robert Shea 
University of Cape Town 
School of Child & Adolescent Health 
Tel: 021 658 5030 
 
Prof M Blockman 
Head Faculty Research Ethics Committee 
University of Cape Town 













               Annexure C 




Enter the interview date.  (dd / mm / yyyy)      |__|__|  / |__|__|  / |__|__|__|__| 
Q02. Enter participant ID number:       |__|__|__|__|__| 
Q03. Enter Interviewer ID number: |__|__|__| 
 
 
BACKGROUND PERSONAL AND MEDICAL INFORMATION 
    
B01. 
a.  How old are you?   
     Or 
b.  What is your date of birth?    (dd/mm /yyyy) 
|__|__| 
|__|__| / |__|__| / |__|__|__|__| 
B02. Where were you born? 
Cape Town 1 
Other Western Cape 2 
Eastern Cape 3 
Other 4 
B03. How long have you lived in Cape Town? 
Years |__|__| 
Refuse to Answer 88 
 
 
















Who do you currently live with?  




a. Partner 1 2 88 
b. Parents     1 2 88 
c. My other child(ren) 1 2 88 
d. Brothers/Sisters 1 2 88 
e. Friends/Other relatives 1 2 88 
f. Alone 1 2 88 
LS03. 
What is your current employment 
status?  
 
Formal employment (specify occupation): 
__________________________________   
1 
Unemployed  2 
Casual employment 3 
Home business [specify: e.g. spaza shop, make 
clothing etc] 4 
Full time housewife 5 
Going to school/college/university 6 
Other 7 
Refuse to answer 88 
LS01. 
Where are you currently living? 
 
[Code one response. Probe for most specific 
living site.] 
A shack on private property 1 
A shack in formal settlement 2 
A house/flat that you own 3 
A house/flat that you rent 4 
A house/flat that you share 5 
Homeless: street 6 
Homeless: shelter 7 
Other 8 





 Now I am going to ask about grant support: Yes No 
LS04. 
Do you receive any grants for yourself or your baby/child?   1 2 
If No, skip to LS06 
LS05. 




a. Child support grant 1 2 
b. Disability grant 1 2 
c. Grant in aid / social relief 1 2 
d. Old age pension  1 2 
e. Child care dependency grant  1 2 
f. Foster care grant 1 2 
g. Child maintenance support [from father]  1 2 




How regular is your income from all sources for the next 6 months, grants included? 
No pattern:  No pattern to how much we get and when. Often we might not  get 
anything. 
1 
Irregular:  We usually get some money each month, but the time and 
 amount varies.  
2 
Mostly fixed:  The date we get money or the amount can change.  3 




Refuse to answer 88 
LS14. 
Do you currently have a regular romantic partner?  
By romantic partner, I mean a husband, boyfriend, 
girlfriend, etc.   
If subject answers “girlfriend” to the following, then 
remember, when asking future questions regarding 
romantic partners, to refer to that person as “she”.  
Husband 1 
Boyfriend 2 
Girlfriend  3 
No 4 
Other (specify): _______ 
____________________ 5 
Refuse to Answer 88 






Other (specify, e.g. Weekends only): 
__________________________________ 
3 
Refuse to answer 88 
LS16. 
Does your partner provide you with any of the following: Yes No 
a. Money 1 2 
b. Food   1 2 
c. Clothing 1 2 
d. Shelter 1 2 




Now I am going to change the subject a bit and ask you questions about HIV. 
 
HT01. 
Were you ever tested for HIV? 
Yes 1 
No 2 
If answer is “No” skip to Pfu_01 
HT02. If yes, what was the result? 
Positive 1 
Negative 2 
Didn’t get the results of the test 3 
Other 4 
Refuse to answer 88 
HT03a. 
Do you have your most recent t-cell or 
CD4 count? 
Yes 1 
Yes, but not available  2 
No, but have taken CD4 test 3 
No, haven’t taken CD4 yet 4 
Refuse to Answer 88 
HT03b. If yes, then what is your t-cell or CD4 count? T-cell or CD4 count: |__|__|__| 







HT05. Has your partner been tested for HIV? 
Yes 1 
No 2 
Don’t know 99 
HT06. Do you know your partner’s HIV status? 
Yes 1 
No 2 
Suspect but don’t 
know for certain 
3 






Have you told your partner your HIV status? 
 





HT09. If yes, what was his response? 
He agreed to get tested 1 
He refused to get tested 2 
He refused to discuss it 3 
Other 4 





























I am going to list a number of different aspects of the 
PMTCT programme, and I want you to tell me which 






a. ARV’s during pregnancy 1 2 99 88 
b. ARV’s at childbirth 1 2 99 88 
c. ARV’s for the new baby 1 2 99 88 
d. Testing the baby 1 2 99 88 
e. Exclusive breastfeeding of baby 1 2 99 88 
f. Exclusive formula feeding of baby 1 2 99 88 
g. Mixed feeding of baby 1 2 99 88 
Pfu_02. 







a. Nevirapine 1 2 99 88 
b. AZT 1 2 99 88 
c. Nevirapine and AZT 1 2 99 88 
Pfu_03. 





a. Nevirapine 1 2 99 88 
b. AZT 1 2 99 88 










Did you take your baby to the well-baby clinic 
for any of the following (at 6 weeks): 
Yes No 
If NO, what was the 
reason? 
a.  Weighing 1 2 
______________________
________________ 
b.  Milk formula 1 2 
______________________
________________ 
c.  Immunization 1 2 
______________________
________________ 




Did you take your baby to the well-baby clinic 
for any of the following (at 14 weeks): 
Yes No 
If NO, what was the 
reason? 
a.  Weighing 1 2 
_____________________
_________________ 
b.  Milk formula 1 2 
_____________________
_________________ 
c.  Immunization 1 2 
_____________________
_________________ 
d.  Because baby was sick 1 2 
_____________________
_________________ 




Since the birth of your baby, has the baby 
been so sick that s/he had to stay in hospital? 
Yes 1 
No 2 
Don’t know 99 
Refuse to answer 88 






Next are some questions about the support that is available to you. 
 
SS01. 
About how many close friends and close relatives do you have (people you feel at ease with and 
can talk to about what is on your mind)? 
SS01a Number of close friends   |__|__|__| 







Someone to help you if you were confined to 
bed. 
1 2 3 4 5 ☺  
B 
Someone you can count on to listen to you when 
you need to talk. 
1 2 3 4 5 ☺  
C Someone to give you good advice about a crisis. 1 2 3 4 5 ☺  
D 
Someone to take you to the doctor if you needed 
it. 
1 2 3 4 5 ☺  
E Someone who shows you love and affection. 1 2 3 4 5 ☺  
F Someone to have a good time with. 1 2 3 4 5 ☺  
G 
Someone to give you information to help you 
understand a situation. 
1 2 3 4 5 ☺  
SS02. 
People sometimes look to others for companionship, assistance, or other types 
of support. 
X=letter of the kind of support in table below 
SS02(X)_1. 
How often is each of the following kinds of support available to you if you need it, and 
how satisfied with this support are you?  
 
Use cups to again represent scale of 1 to 5: 
1=None of the time 
2=A little of the time  
3=Some of the time  
4=Most of the time 
 5=All of the time 
SS02(X)_2. Circle the happy or frown face to signify how satisfied you are with the support. 
 






Someone to confide in or talk to about yourself 
or your problems. 
1 2 3 4 5 ☺  
I Someone who hugs you. 1 2 3 4 5 ☺  
J Someone to get together with for relaxation. 1 2 3 4 5 ☺  
K 
Someone to prepare your meals if you were 
unable to do it yourself. 
1 2 3 4 5 ☺  
L Someone whose advice you really want. 1 2 3 4 5 ☺  
M 
Someone to do things with to help you get your 
mind off things. 
1 2 3 4 5 ☺  
N 
Someone to help with daily chores if you were 
sick. 
1 2 3 4 5 ☺  
O 
Someone to share your most private worries and 
fears with. 
1 2 3 4 5 ☺  
P 
Someone to turn to for suggestions about how to 
deal with a personal problem. 
1 2 3 4 5 ☺  
Q Someone to do something enjoyable with. 1 2 3 4 5 ☺  
R Someone who understands your problems. 1 2 3 4 5 ☺  
S Someone to love and make you feel wanted. 1 2 3 4 5 ☺  
T 
Someone to help take care of your children 
when you can’t. 














Because of your HIV, have you ever experienced any of the following?  
a. Told you couldn’t go to someone’s house because of HIV. 1 2 88 
b. Couldn’t play with someone else’s children because of HIV. 1 2 88 
c. Can’t eat with or on their plates or can’t use their glasses or knives and 
forks because of HIV. 
1 2 88 
d. Can’t touch or hug someone because of HIV. 1 2 88 
e. Can’t cook food because of HIV. 1 2 88 
f. Can’t use someone’s toilet because of HIV.  1 2 88 
g. Was laughed at or teased because of HIV. 1 2 88 
h. Was fired from a job because of HIV. 1 2 88 
i. Told you can’t live somewhere because of HIV.  1 2 88 
j. Had your HIV status told without your permission. 1 2 88 













Did you discuss getting HIV tested with your partner before 
you agreed to have the test? . 
1 2 99 88 
D02 
Does your partner now know that you went to get tested for 
HIV? 
1 2 99 88 
D03a 
Have you told your partner or does he know your HIV test 
result? 
1 2 99 88 
D03b 
If yes, how supportive was he/she? 
Use feeling faces to gauge the level of support 
they received from their partner. 
☺   Very supportive 1 
   Somewhat supportive 2 
   Unsupportive 3 
D04a-d 
Who else have you told your HIV status to? 







☺   Very supportive 1 
   Somewhat supportive 2 
   Unsupportive 3 
      Did not tell them 4 
      Refuse to answer 88 
D04b Friends 
☺   Very supportive 1 
   Somewhat supportive 2 
   Unsupportive 3 
      Did not tell them 4 
      Refuse to answer 88 
D04c Health care workers 
☺   Very supportive 1 
   Somewhat supportive 2 
   Unsupportive 3 
      Did not tell them 4 
      Refuse to answer 88 
D04d Other 
☺   Very supportive 1 
   Somewhat supportive 2 
   Unsupportive 3 
      Did not tell them 4 




 PARENTING  
 
CHILDREN 
CH01 Was this pregnancy your first child? 
Yes 1 
No 2 
Refuse to answer 88 
CH02 
If no, how old were you the first time you 
had a baby? 
|__|__| |__|__| 
Never had a baby before this one 2 
Refuse to answer 88 
CH03a 
How many children have you given birth 
to?   
|__|__| |__|__| 
Refuse to answer 88 
CH03b How many children are still alive?   
|__|__| |__|__| 
Refuse to answer 88 
 
Open-ended Questions: 
1. When did you first tell your child about their health status? 
2. What did you say exactly? Please pretend that the translator is your child and repeat 
exactly what you said to your child at the time 
3. What was the reason that you decided to tell your child about their health status at that 
time? 
4. How many times has your child ever asked you or others or given any indications 
about their concern about their health and coming to the hospital? How did you 
respond in those situations? How did you feel when that happened? 
5. What were your worries/fears about telling the child the real reason that they come to 
the hospital? What did you actually say to the child? 
6. How did it feel when you did/did not tell the child exactly about their health 
condition? 
7. What was the child’s reaction to what you said or did not say? 
8. Is there anything I have not asked you about talking to your child about their health 
that you would like to talk about? Are there any questions you would like me to 
answer? 
9. What was it like for you to be asked these questions? 

















Annexure D  
Translated Consent Form 
 
Injongo zokufunda  
Uyamenywa ukuba uthathe inxaxheba kwiprojekthi yophando ezakuba ikhokhelwa 
ngabaphandi abaphuma ku Dyunivesithi yase Kapa. Injongo zesifundo kukufuna ukuqonda 
ngcono ukuba zintoni kwaye besenza njani abaniki boncedo ukuqhakamshelana nabantwana 
malunga nempilo yabo kunye notyelelo lwabo ezibhedlele. Abaniki luncedo baqhuba iS4 
Clinic e Red Cross War Memorial. Isibhedlele sabantwana sizakumenywa ukuba 
sizokuthabatha inxaxheba kwesi sifundo. Siyathemba ukuba iziphumo zesifundo ziyakunceda 
kakhulu ukuphucula impilo nohanjiso lweenkonzo kubantwana ndawonye nezihlobo 
nezelamana.  
Imigaqo yokufunda  
Ukuba ugqibe ekubeni uthathe inxaxheba kwizifundo ngophando, uyakuba nodliwanondlebe 
ngumphandi okanye ngumphandi okanye umphandi oncedisayo udliwano-ndlebe alusayi 
kuthatha ngaphezulu kwemizuzu e 30 – 45.  
Udliwano-ndlebe luyakushicilelwa kwi tape recorder khonukuze umphandi abe 
namanqakwana awabhala phantsi azokukwazi ukuwamamelisisa kakuhle. Yeyonanto 
izakunceda umphandi ukuba ayiqonde ngokucacileyo ukuba zintoni ezithethwe ngabantwana 
nabaniki luncedo. Yonke into ethe yashicilelwa yaze yabhalwa emaphepheni ngelaa xesha 
bekusenziwa udliwano-ndlebe, iyagcinwa ukuze itshixelwe ekhanjini kwi office yabaphandi. 
Ngumphandi okanye umncedisi womphandi onelungelo lokuyakuvula phaya.  
Abasebenzi besebe lezempilo  ezibhedlele abasayi kuba nalungelo lwale ngcombolo, 
nenxaxheba othe wayithatha kwesi sifundo ayisayi kubachaphazela uncedo umntwana 
alufumanayo. 
Ukuthabatha inxaxheba ungajonganga nzuzo 
• Ukuthabatha inxaxheba kwesi sifundo ku volontari  
• Unelungelo lokungayiphenduli imibuzo oyibuzwayo ukuba ugqibe ekuseni, uthabathe 
inxaxheba kwesi sifundo, unelungelo lokusitshintsha nangaliphi ixesha xa ufuna. 
Loonto ayisayi kuluchaphazela uncedo olufunyanwe ngabantwana.  
Okuyimfihlo  
Iingcombolo mazibe yimfihlo. Iimpepha zo dliwano-ndlebe noshicilelo malungabikho igama 
lakho kuzo. Mazingabikho neengcombolo ezoya nyaniswa naye nabani, naziphi na iziphumo 
nezibhengezo ngokwesi sifundo mayingoyanyaniswa nawe,nomntwana okanye nabani na 
ongumthathi nxaxheba.  
 
 
Ingxaki ezinokwenzeka  
Ngeli xesha uthathi nxaxheba kwezi zifundo zophando, usenokufumana ungonwabi 
emphefumlweni. Ukuba loonto yenzekile unelungelo lukuthetha nono ntlalontle okanye i 
khansela, uyakunika ithuba lalonto.  
Iinzuzo ezilindelekileyo  
Uyakuzuza wena buqu xa unokuthetha ngamava wakho onokuthi wabelane, uthethe 
ngokuyimfihlo nabantwana ngempilo yabo. 
• Esi sifundo siphuculwe yi Research Ethnics Committee kwi Dyunivesithi yase Kapa.  
• Ukuba nangaliphi na ixesha unemibuzo okanye izinto onazo ngesi sifundo, nceda 






Email: ourfertileground@gmail.com  
 
Imvume yomthathi-nxaxheba 
Ndizifundile inkcukacha zolwazi olungaphezulu kwaye ndizifundelwe. Ndilifumene ithuba 




Intsayino-gama:……………………  Umhla:……………………………. 
Ubuthathaka:………………………  Intsayino-gama:…………………… 
 
Ukuba kunzima ukubhala: Inkcukatha zicacisiwe ngumhlalutyi, ngolwimi lwam. 
 
Intsayino-gama:……………………  Umhla:……………………………. 
Ubuthathaka:………………………  Intsayino-gama:…………………… 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
